| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 KIFC1 WRN DDX55 ATP10D ORC4 ABCB9 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 1.99e-07 | 441 | 273 | 22 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 STARD9 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 DYNC1I2 KIFC1 WRN DDX55 ATP10D ORC4 ABCB9 MYH14 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 1.28e-06 | 614 | 273 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PEX14 ADGRV1 PTK2 SPTBN5 WASH6P PTPRC STARD9 SVIL NAV3 DMD USH2A MTUS2 KIFC1 TRIM46 FLNB WASL LIMA1 EPB41L4B NUMA1 PKD2L1 DNM1L GRIA2 C10orf90 PSTPIP1 EGFR XIRP2 MYH14 MACO1 ENAH CEP295 CTNNA1 SSH2 ATP1A1 CROCC | 7.48e-06 | 1099 | 273 | 34 | GO:0008092 |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 2.48e-05 | 5 | 273 | 3 | GO:0004459 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 KIFC1 SEPTIN5 WRN DNM1L DDX55 RGS12 GFM2 ATP10D ORC4 ABCB9 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 2.48e-05 | 775 | 273 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 4.90e-05 | 6 | 273 | 3 | GO:0004457 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 KIFC1 SEPTIN5 WRN DNM1L DDX55 RGS12 GFM2 ATP10D ORC4 ABCB9 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 9.21e-05 | 839 | 273 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 KIFC1 SEPTIN5 WRN DNM1L DDX55 RGS12 GFM2 ATP10D ORC4 ABCB9 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 9.39e-05 | 840 | 273 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX59 ABCA4 EIF4A3 PEX1 SRCAP IFIH1 ABCC8 DDX18 NAV3 CHD6 HSPA1L HSPA9 KIFC1 SEPTIN5 WRN DNM1L DDX55 RGS12 GFM2 ATP10D ORC4 ABCB9 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 9.39e-05 | 840 | 273 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | sour taste receptor activity | 1.86e-04 | 2 | 273 | 2 | GO:0033040 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH23 TENM2 PTK2 FGB TJP2 PKP2 FGF2 DMD STK24 SDCBP CNTN2 VCAM1 CCS FLNB LIMA1 TENM4 EGFR CTNNA1 PCBP1 TNXB | 2.33e-04 | 599 | 273 | 20 | GO:0050839 |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 6.20e-04 | 29 | 273 | 4 | GO:0043395 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.47e-04 | 51 | 273 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.52e-04 | 109 | 273 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 8.83e-04 | 112 | 273 | 7 | GO:0090079 | |
| GeneOntologyMolecularFunction | actin binding | PTK2 SPTBN5 WASH6P SVIL DMD FLNB WASL LIMA1 PSTPIP1 EGFR XIRP2 MYH14 ENAH CTNNA1 SSH2 CROCC | 9.71e-04 | 479 | 273 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | intermediate filament binding | 1.02e-03 | 15 | 273 | 3 | GO:0019215 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.10e-03 | 4 | 273 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | microtubule binding | PEX14 STARD9 NAV3 MTUS2 KIFC1 TRIM46 WASL NUMA1 DNM1L C10orf90 MACO1 CEP295 | 1.15e-03 | 308 | 273 | 12 | GO:0008017 |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 2.15e-05 | 5 | 269 | 3 | GO:0048496 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | CYP2J2 TSC2 PTK2 HP1BP3 KIAA0319 SPTBN5 WASH6P SVIL FGB CNTN2 TRIM46 LIMA1 RAP1GDS1 BAG4 CCDC51 EGFR LRP1 KANK4 SSH2 ATP2B1 ATP2B2 IL7R | 2.21e-05 | 618 | 269 | 22 | GO:0090066 |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 3.19e-05 | 47 | 269 | 6 | GO:0045494 | |
| GeneOntologyCellularComponent | actin cytoskeleton | DAPK1 PTK2 SPTBN5 SVIL VCAM1 FLNB WASL LIMA1 SEPTIN5 PKD2L1 C10orf90 PSTPIP1 BCAR1 ARHGAP6 INTS6 SH3PXD2B XIRP2 MYH14 ENAH EFR3B CTNNA1 CROCC | 7.64e-06 | 576 | 273 | 22 | GO:0015629 |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 PTK2 PTPRC SVIL DMD HSPA9 SDCBP FLNB FBLN7 LIMA1 BCAR1 EGFR XIRP2 ENAH LRP1 CTNNA1 SSH2 PCBP2 | 2.33e-05 | 443 | 273 | 18 | GO:0030055 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | CDH23 ADGRV1 ANKS4B RSC1A1 ITPR3 USH2A ALPI FLNB LIMA1 DNM1L CUBN MYH14 | 3.94e-05 | 223 | 273 | 12 | GO:0098862 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 8.16e-05 | 107 | 273 | 8 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 8.16e-05 | 107 | 273 | 8 | GO:0001725 | |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 MPDZ GRHL2 TENM2 PTK2 PTPRC SVIL TJP2 PKP2 DMD HSPA9 SDCBP FLNB FBLN7 LIMA1 RPGRIP1L EPB41L4B CNTNAP1 BCAR1 SH3PXD2B EGFR XIRP2 ENAH LRP1 CTNNA1 SSH2 ATP1A1 PCBP2 | 8.46e-05 | 976 | 273 | 28 | GO:0070161 |
| GeneOntologyCellularComponent | actomyosin | 1.53e-04 | 117 | 273 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.62e-04 | 118 | 273 | 8 | GO:0032432 | |
| GeneOntologyCellularComponent | brush border | 1.79e-04 | 152 | 273 | 9 | GO:0005903 | |
| GeneOntologyCellularComponent | focal adhesion | PTK2 PTPRC SVIL HSPA9 SDCBP FLNB FBLN7 LIMA1 BCAR1 EGFR XIRP2 ENAH LRP1 CTNNA1 SSH2 PCBP2 | 1.88e-04 | 431 | 273 | 16 | GO:0005925 |
| GeneOntologyCellularComponent | membrane raft | TSC2 UNC5A PTPRC DMD SDCBP CAVIN2 LDHB MYOF EGFR LRP4 CAVIN1 CTNNA1 ATP1A1 GASK1A | 3.13e-04 | 362 | 273 | 14 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | TSC2 UNC5A PTPRC DMD SDCBP CAVIN2 LDHB MYOF EGFR LRP4 CAVIN1 CTNNA1 ATP1A1 GASK1A | 3.31e-04 | 364 | 273 | 14 | GO:0098857 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 3.96e-04 | 48 | 273 | 5 | GO:0032391 | |
| GeneOntologyCellularComponent | RQC complex | 5.05e-04 | 3 | 273 | 2 | GO:1990112 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 5.49e-04 | 78 | 273 | 6 | GO:0001917 | |
| GeneOntologyCellularComponent | myelin sheath | MPDZ ITPR3 HSPA9 CNTN2 CNTNAP1 PRDX2 LDHB MYH14 ATP1A1 ATP1A3 | 5.94e-04 | 217 | 273 | 10 | GO:0043209 |
| GeneOntologyCellularComponent | caveola | 6.42e-04 | 111 | 273 | 7 | GO:0005901 | |
| GeneOntologyCellularComponent | plasma membrane raft | 7.13e-04 | 147 | 273 | 8 | GO:0044853 | |
| GeneOntologyCellularComponent | neuron projection membrane | 7.17e-04 | 82 | 273 | 6 | GO:0032589 | |
| GeneOntologyCellularComponent | apical part of cell | STK26 CDH23 MPDZ PTK2 ITPR3 SPTBN5 NOD1 AP2A1 USH2A VCAM1 EPB41L4B NUMA1 CUBN EGFR LRP1 ATP1A1 ATP2B1 ATP2B2 | 8.32e-04 | 592 | 273 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | cell leading edge | ADGRV1 PTK2 UNC5A WASH6P DMD USH2A WASL LIMA1 GRIA2 PSTPIP1 BCAR1 EGFR ENAH CTNNA1 ATP2B1 ATP2B2 | 9.46e-04 | 500 | 273 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 1.00e-03 | 4 | 273 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | USH2 complex | 1.00e-03 | 4 | 273 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | actin-based cell projection | CDH23 ADGRV1 ANKS4B TENM2 WASH6P AP2A1 DMD USH2A VCAM1 CUBN ENAH | 1.13e-03 | 278 | 273 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 1.31e-03 | 17 | 273 | 3 | GO:0090443 | |
| GeneOntologyCellularComponent | COP9 signalosome | 1.48e-03 | 38 | 273 | 4 | GO:0008180 | |
| GeneOntologyCellularComponent | microtubule end | 1.48e-03 | 38 | 273 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 1.55e-03 | 18 | 273 | 3 | GO:0098684 | |
| GeneOntologyCellularComponent | omegasome | 1.66e-03 | 5 | 273 | 2 | GO:1990462 | |
| GeneOntologyCellularComponent | postsynapse | EIF4A3 MPDZ DAPK1 TSC2 TENM2 PTK2 AP2A1 STRN4 PLEKHA5 DMD CNTN2 WASL NPTX2 GRIA2 GRIA4 TRIM3 FXR1 LRP1 LRP4 ATP1A1 ATP1A3 PCBP1 PCBP2 ATP2B1 ATP2B2 | 1.90e-03 | 1018 | 273 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.95e-03 | 212 | 273 | 9 | GO:0030666 | |
| GeneOntologyCellularComponent | microtubule organizing center | CDC14C DZIP1L CDH23 PTK2 WASH6P STARD9 CROCC2 USH2A MTUS2 CFAP410 DYNC1I2 KIFC1 RPGRIP1L UBXN6 WRN NUMA1 C10orf90 CCDC77 CCDC141 MYOF LRP1 CEP295 CROCC | 2.26e-03 | 919 | 273 | 23 | GO:0005815 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.35e-03 | 43 | 273 | 4 | GO:0032809 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 2.46e-03 | 6 | 273 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 2.46e-03 | 6 | 273 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.46e-03 | 6 | 273 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 2.46e-03 | 6 | 273 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | costamere | 2.82e-03 | 22 | 273 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cell body membrane | 3.27e-03 | 47 | 273 | 4 | GO:0044298 | |
| GeneOntologyCellularComponent | microtubule minus-end | 3.42e-03 | 7 | 273 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | INSRR CDH23 MPDZ KCNQ5 AP2A1 ABCC8 DMD C9 SDCBP VCAM1 EVC2 GRIA2 GRIA4 FAF1 EGFR KCNQ4 LRP1 CTNNA1 ATP1A1 ATP1A3 | 3.54e-03 | 785 | 273 | 20 | GO:0098797 |
| Domain | PC1 | 1.17e-05 | 4 | 269 | 3 | IPR000434 | |
| Domain | L-lactate_DH_AS | 2.89e-05 | 5 | 269 | 3 | IPR018177 | |
| Domain | L_LDH | 2.89e-05 | 5 | 269 | 3 | PS00064 | |
| Domain | L-lactate_DH | 2.89e-05 | 5 | 269 | 3 | IPR011304 | |
| Domain | KH_dom_type_1 | 3.76e-05 | 44 | 269 | 6 | IPR004088 | |
| Domain | ATPase_P-typ_TM_dom | 6.68e-05 | 16 | 269 | 4 | IPR023298 | |
| Domain | - | 6.68e-05 | 16 | 269 | 4 | 1.20.1110.10 | |
| Domain | Cation_ATPase_C | 8.64e-05 | 17 | 269 | 4 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 8.64e-05 | 17 | 269 | 4 | IPR006068 | |
| Domain | - | 8.75e-05 | 32 | 269 | 5 | 3.40.1110.10 | |
| Domain | - | 8.75e-05 | 32 | 269 | 5 | 2.70.150.10 | |
| Domain | Ig-like_fold | SIGLEC8 INSRR SIGLEC5 KIAA0319 IGSF10 UNC5A PTPRC ALPK3 POGLUT2 USH2A CNTN2 VCAM1 TRIM46 NDNF FLNB MXRA5 COL12A1 SIGLEC14 CCDC141 EXOSC2 TRIM3 ASTN1 TNXB IL7R | 9.25e-05 | 706 | 269 | 24 | IPR013783 |
| Domain | P-loop_NTPase | DDX59 ABCA4 EIF4A3 PEX1 DAPK1 SLFN5 SRCAP ZFYVE1 IFIH1 NOD1 STARD9 ABCC8 DDX18 NAV3 TJP2 CHD6 GIMAP6 KIFC1 SEPTIN5 MTHFD1L WRN DNM1L DDX55 GFM2 ORC4 ABCB9 MYH14 | 1.01e-04 | 848 | 269 | 27 | IPR027417 |
| Domain | Cation_ATPase_N | 1.10e-04 | 18 | 269 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.10e-04 | 18 | 269 | 4 | SM00831 | |
| Domain | ARM-type_fold | DCAF1 DOCK11 TSC2 USP9Y EFR3A AP2A1 EIF2B5 PKP2 UTP20 NIPBL RAP1GDS1 HEATR4 PAIP1 LTN1 EFR3B | 1.27e-04 | 339 | 269 | 15 | IPR016024 |
| Domain | ATPase_P-typ_cyto_domN | 1.36e-04 | 35 | 269 | 5 | IPR023299 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.38e-04 | 19 | 269 | 4 | IPR004014 | |
| Domain | ATPase_P-typ_P_site | 1.56e-04 | 36 | 269 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 1.56e-04 | 36 | 269 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.56e-04 | 36 | 269 | 5 | PS00154 | |
| Domain | Lactate/malate_DH_N | 1.57e-04 | 8 | 269 | 3 | IPR001236 | |
| Domain | L-lactate/malate_DH | 1.57e-04 | 8 | 269 | 3 | IPR001557 | |
| Domain | Ldh_1_N | 1.57e-04 | 8 | 269 | 3 | PF00056 | |
| Domain | Helicase_C | 1.59e-04 | 107 | 269 | 8 | PF00271 | |
| Domain | HELICc | 1.59e-04 | 107 | 269 | 8 | SM00490 | |
| Domain | Helicase_C | 1.70e-04 | 108 | 269 | 8 | IPR001650 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.79e-04 | 37 | 269 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.79e-04 | 37 | 269 | 5 | PF00122 | |
| Domain | DEXDc | 1.81e-04 | 109 | 269 | 8 | SM00487 | |
| Domain | HELICASE_CTER | 1.81e-04 | 109 | 269 | 8 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.81e-04 | 109 | 269 | 8 | PS51192 | |
| Domain | Helicase_ATP-bd | 1.93e-04 | 110 | 269 | 8 | IPR014001 | |
| Domain | KH_1 | 2.03e-04 | 38 | 269 | 5 | PF00013 | |
| Domain | SUI1_euk | 2.07e-04 | 2 | 269 | 2 | IPR005874 | |
| Domain | TMEM183 | 2.07e-04 | 2 | 269 | 2 | IPR026509 | |
| Domain | - | 2.30e-04 | 39 | 269 | 5 | 3.30.1370.10 | |
| Domain | - | 2.30e-04 | 39 | 269 | 5 | 2.120.10.30 | |
| Domain | - | 2.33e-04 | 9 | 269 | 3 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 2.33e-04 | 9 | 269 | 3 | IPR022383 | |
| Domain | Ldh_1_C | 2.33e-04 | 9 | 269 | 3 | PF02866 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 2.33e-04 | 9 | 269 | 3 | IPR015955 | |
| Domain | FN3_dom | INSRR KIAA0319 PTPRC USH2A CNTN2 TRIM46 NDNF COL12A1 ASTN1 TNXB IL7R | 2.33e-04 | 209 | 269 | 11 | IPR003961 |
| Domain | - | SIGLEC8 INSRR SIGLEC5 IGSF10 UNC5A PTPRC ALPK3 POGLUT2 USH2A CNTN2 VCAM1 TRIM46 NDNF FLNB MXRA5 COL12A1 SIGLEC14 CCDC141 TRIM3 ASTN1 TNXB IL7R | 2.55e-04 | 663 | 269 | 22 | 2.60.40.10 |
| Domain | KH_dom | 2.60e-04 | 40 | 269 | 5 | IPR004087 | |
| Domain | KH | 2.60e-04 | 40 | 269 | 5 | SM00322 | |
| Domain | KH_TYPE_1 | 3.29e-04 | 42 | 269 | 5 | PS50084 | |
| Domain | IG_FLMN | 3.29e-04 | 10 | 269 | 3 | SM00557 | |
| Domain | EGF_1 | TENM2 C9 USH2A FBLN7 CNTNAP1 LAMA4 CUBN TENM4 LRP1 LRP4 ASTN1 TNXB | 3.43e-04 | 255 | 269 | 12 | PS00022 |
| Domain | FN3 | INSRR KIAA0319 PTPRC USH2A CNTN2 TRIM46 NDNF COL12A1 ASTN1 TNXB | 3.61e-04 | 185 | 269 | 10 | SM00060 |
| Domain | Filamin | 4.48e-04 | 11 | 269 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 4.48e-04 | 11 | 269 | 3 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 4.48e-04 | 11 | 269 | 3 | IPR017868 | |
| Domain | Filamin/ABP280_rpt | 4.48e-04 | 11 | 269 | 3 | IPR001298 | |
| Domain | PKD_channel | 4.48e-04 | 11 | 269 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 4.48e-04 | 11 | 269 | 3 | IPR013122 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.05e-04 | 46 | 269 | 5 | IPR011042 | |
| Domain | - | DDX59 ABCA4 EIF4A3 PEX1 SLFN5 SRCAP ZFYVE1 IFIH1 NOD1 ABCC8 DDX18 NAV3 TJP2 CHD6 GIMAP6 SEPTIN5 MTHFD1L WRN DNM1L DDX55 GFM2 ORC4 ABCB9 | 5.21e-04 | 746 | 269 | 23 | 3.40.50.300 |
| Domain | ARM-like | DCAF1 TSC2 USP9Y EFR3A AP2A1 PKP2 UTP20 NIPBL RAP1GDS1 HEATR4 LTN1 EFR3B | 5.72e-04 | 270 | 269 | 12 | IPR011989 |
| Domain | Rhs_assc_core | 6.14e-04 | 3 | 269 | 2 | IPR022385 | |
| Domain | ALMS_motif | 6.14e-04 | 3 | 269 | 2 | IPR029299 | |
| Domain | ALMS_motif | 6.14e-04 | 3 | 269 | 2 | PF15309 | |
| Domain | FN3 | 6.40e-04 | 199 | 269 | 10 | PS50853 | |
| Domain | - | 6.89e-04 | 74 | 269 | 6 | 3.40.50.410 | |
| Domain | NHL | 7.59e-04 | 13 | 269 | 3 | PS51125 | |
| Domain | EGF-like_dom | TENM2 C9 FBLN7 CNTNAP1 LAMA4 CUBN TENM4 LRP1 LRP4 ASTN1 TNXB | 1.01e-03 | 249 | 269 | 11 | IPR000742 |
| Domain | VWFA | 1.18e-03 | 82 | 269 | 6 | PS50234 | |
| Domain | Cavin_fam | 1.22e-03 | 4 | 269 | 2 | IPR026752 | |
| Domain | Tox-GHH_dom | 1.22e-03 | 4 | 269 | 2 | IPR028916 | |
| Domain | DUF4217 | 1.22e-03 | 4 | 269 | 2 | PF13959 | |
| Domain | Tox-GHH | 1.22e-03 | 4 | 269 | 2 | PF15636 | |
| Domain | PTRF_SDPR | 1.22e-03 | 4 | 269 | 2 | PF15237 | |
| Domain | Ten_N | 1.22e-03 | 4 | 269 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.22e-03 | 4 | 269 | 2 | PS51361 | |
| Domain | DUF4217 | 1.22e-03 | 4 | 269 | 2 | IPR025313 | |
| Domain | ATP_Ca_trans_C | 1.22e-03 | 4 | 269 | 2 | IPR022141 | |
| Domain | - | 1.22e-03 | 4 | 269 | 2 | 3.30.780.10 | |
| Domain | ATP_Ca_trans_C | 1.22e-03 | 4 | 269 | 2 | PF12424 | |
| Domain | SUI1 | 1.22e-03 | 4 | 269 | 2 | PF01253 | |
| Domain | Ten_N | 1.22e-03 | 4 | 269 | 2 | IPR009471 | |
| Domain | SUI1 | 1.22e-03 | 4 | 269 | 2 | PS50296 | |
| Domain | DUF4217 | 1.22e-03 | 4 | 269 | 2 | SM01178 | |
| Domain | P-type_ATPase_IIB | 1.22e-03 | 4 | 269 | 2 | IPR006408 | |
| Domain | RNA-helicase_DEAD-box_CS | 1.24e-03 | 33 | 269 | 4 | IPR000629 | |
| Domain | VWA | 1.25e-03 | 56 | 269 | 5 | PF00092 | |
| Domain | ConA-like_dom | COL22A1 ADGRV1 USH2A TRIM46 NPTX2 COL12A1 TRIM41 CNTNAP1 LAMA4 TRIM5 | 1.33e-03 | 219 | 269 | 10 | IPR013320 |
| Domain | VWA | 1.34e-03 | 84 | 269 | 6 | SM00327 | |
| Domain | Laminin_G | 1.47e-03 | 58 | 269 | 5 | IPR001791 | |
| Domain | - | DCAF1 TSC2 EFR3A AP2A1 PKP2 UTP20 NIPBL RAP1GDS1 HEATR4 EFR3B | 1.47e-03 | 222 | 269 | 10 | 1.25.10.10 |
| Domain | EGF-like_CS | TENM2 C9 FBLN7 CNTNAP1 LAMA4 CUBN TENM4 LRP1 LRP4 ASTN1 TNXB | 1.47e-03 | 261 | 269 | 11 | IPR013032 |
| Domain | Q_MOTIF | 1.91e-03 | 37 | 269 | 4 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.91e-03 | 37 | 269 | 4 | IPR014014 | |
| Domain | HAT_MYST-type | 2.01e-03 | 5 | 269 | 2 | IPR002717 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 2.01e-03 | 5 | 269 | 2 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 2.01e-03 | 5 | 269 | 2 | IPR003937 | |
| Domain | MYST_HAT | 2.01e-03 | 5 | 269 | 2 | PS51726 | |
| Domain | YD | 2.01e-03 | 5 | 269 | 2 | IPR006530 | |
| Domain | MOZ_SAS | 2.01e-03 | 5 | 269 | 2 | PF01853 | |
| Domain | SUI1 | 2.01e-03 | 5 | 269 | 2 | IPR001950 | |
| Domain | KCNQ_channel | 2.01e-03 | 5 | 269 | 2 | PF03520 | |
| Pubmed | NES DOCK11 MPDZ DAPK1 TSC2 FYCO1 TENM2 ITIH1 PTK2 KIAA0319 AP2A1 SVIL STRN4 FBXO41 PEX5 PLEKHA5 NIPBL HSPA9 TRIM46 LIMA1 RGPD8 SEPTIN5 ZNF618 CNTNAP1 NUMA1 DNM1L GRIA2 GRIA4 PRDX2 TRIM3 SH3PXD2B UBE2O FXR1 ENAH LRP1 CTNNA1 SSH2 PCBP1 | 7.26e-16 | 963 | 280 | 38 | 28671696 | |
| Pubmed | MTA2 NES STK26 DAPK1 RRBP1 HP1BP3 AP2A1 SVIL STRN4 FBXO41 TJP2 PLEKHA5 DMD MTUS2 HSPA9 SDCBP CNTN2 TRIM46 FLNB WASL LIMA1 RAP1GDS1 SEPTIN5 EPB41L4B CNTNAP1 DNM1L GRIA2 PRDX2 LDHB TRIM3 UBE2O FXR1 TENM4 MYH14 CTNNA1 SSH2 ATP1A1 ATP1A3 CROCC PCBP1 ATP2B1 ATP2B2 | 4.52e-13 | 1431 | 280 | 42 | 37142655 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EDF1 DDX59 EPPK1 EIF4A3 PFAS TSC2 TSNAX RRBP1 HP1BP3 CIRBP AP2A1 JMJD6 DDX18 ACBD3 NIPBL HSPA9 SDCBP DYNC1I2 FLNB MTHFD1L NUMA1 PRDX2 DDX55 CCDC51 LDHB EXOSC2 ORC4 UBE2O FXR1 DNAJC17 PAXBP1 EGFR NEMF ENAH CAVIN1 CTNNA1 ATP1A1 PCBP1 PCBP2 | 2.24e-11 | 1415 | 280 | 39 | 28515276 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MTA2 NES EDF1 EPPK1 PEX14 PFAS HP1BP3 AP2A1 SUPT5H DDX18 A2ML1 CIAPIN1 TJP2 COPS6 HSPA1L FUBP3 HSPA9 DYNC1I2 FLNB LIMA1 RAP1GDS1 MTHFD1L PRDX2 LDHB PAIP1 FAF1 MYOF SH3PXD2B UBE2O FXR1 RCL1 LRP1 CAVIN1 CTNNA1 NUDCD1 ATP1A1 PCBP1 PCBP2 | 3.25e-11 | 1367 | 280 | 38 | 32687490 |
| Pubmed | EIF4A3 NCKAP5 TSC2 ZNF224 RRBP1 USP9Y PTK2 AP2A1 SUPT5H DDX18 PKD1 NAV3 CHD6 ACBD3 COPS5 NIPBL MTUS2 HSPA9 SDCBP FLNB WASL RAP1GDS1 ADAMTS1 CNTNAP1 ANKRD6 TRIM5 FAF1 UBE2O MYH14 NEMF LRP1 LRP4 ASTN1 ANKRD36 CTNNA1 PCBP1 | 9.13e-11 | 1285 | 280 | 36 | 35914814 | |
| Pubmed | EIF4A3 DZIP1L TM9SF3 RRBP1 SRCAP PSMA8 HP1BP3 AP2A1 STARD9 EFCAB12 STRN4 CHD6 DMD HSPA1L FUBP3 NIPBL HSPA9 CAVIN2 DYNC1I2 FLNB LIMA1 RGPD8 CHAF1A PARP8 NUMA1 GRIA2 GRIA4 CCDC77 DDX55 FXR1 ABCB9 MYH14 CEP295 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 5.59e-10 | 1442 | 280 | 37 | 35575683 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | MGAT4A PEX14 TSNAX GLB1 SVIL TJP2 PLEKHA5 STK24 NIPBL SDCBP LIMA1 PAIP1 FAF1 PPM1B INTS6 SIDT2 TENM4 RCL1 ENAH TEN1 PCBP2 ATP2B1 | 5.87e-10 | 536 | 280 | 22 | 15840001 |
| Pubmed | MGAT4A PEX14 TSNAX GLB1 SVIL TJP2 PLEKHA5 STK24 NIPBL SDCBP LIMA1 PAIP1 FAF1 PPM1B INTS6 SIDT2 TENM4 RCL1 ENAH TEN1 PCBP2 ATP2B1 | 6.30e-10 | 538 | 280 | 22 | 10512203 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MTA2 EPPK1 EIF4A3 RRBP1 HP1BP3 ITPR3 AP2A1 DDX18 SVIL PKP2 UTP20 HSPA9 KIFC1 FLNB LIMA1 EPB41L4B NUMA1 PRDX2 BCAR1 DDX55 LDHB FAF1 FXR1 MYH14 CAVIN1 CTNNA1 ATP1A1 PCBP1 PCBP2 | 1.01e-09 | 949 | 280 | 29 | 36574265 |
| Pubmed | NES EPPK1 ZNF274 FYCO1 HP1BP3 ITPR3 SVIL PKP2 PLEKHA5 SDCBP CAVIN2 FLNB LIMA1 RAP1GDS1 ADAMTS1 LDHB EXOSC2 MYH14 CAVIN1 SSH2 ATP1A1 | 1.08e-09 | 503 | 280 | 21 | 36217030 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | DCAF1 RRBP1 ITPR3 UTP20 FLNB CNTNAP1 WRN NUMA1 ICE1 MYOF EGFR MYH14 LTN1 ATP1A1 | 1.23e-09 | 202 | 280 | 14 | 33005030 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 MTA2 NES EIF4A3 PFAS RRBP1 SRCAP ANKRD27 PTK2 AP2A1 DDX18 A2ML1 EIF2B5 PKP2 UTP20 PLEKHA5 ERP29 HSPA1L FUBP3 NIPBL HSPA9 DYNC1I2 FLNB MTHFD1L NUMA1 PRDX2 LDHB KAT7 FXR1 MYH14 RCL1 LTN1 CAVIN1 PCBP1 ATP2B1 | 1.39e-09 | 1353 | 280 | 35 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MTA2 EIF4A3 TM9SF3 PFAS RRBP1 AP2A1 SUPT5H STARD9 DDX18 EIF2B5 UTP20 ERP29 FUBP3 NIPBL HSPA9 SDCBP KIFC1 FLNB MTHFD1L CHAF1A NUMA1 DNM1L PRDX2 DDX55 LDHB UBE2O FXR1 PAXBP1 MYH14 RCL1 NEMF ENAH GALNT5 ATP1A1 PCBP1 ATP2B1 | 1.48e-09 | 1425 | 280 | 36 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MTA2 EIF4A3 STK26 PFAS TSNAX JMJD6 SUPT5H CIAPIN1 STRN4 PEX5 TJP2 COPS6 HSPA1L ACBD3 COPS5 FUBP3 STK24 HSPA9 DYNC1I2 FLNB RAP1GDS1 LDHAL6B DNM1L PRDX2 BCAR1 LDHB EXOSC2 PAIP1 FAF1 UBE2O MYH14 ENAH CTNNA1 NUDCD1 CROCC PCBP1 | 2.56e-09 | 1455 | 280 | 36 | 22863883 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MTA2 NES EPPK1 STK26 MPDZ PFAS CIRBP AP2A1 SVIL ERP29 COPS6 HSPA1L ACBD3 HSPA9 DYNC1I2 FLNB LIMA1 ADAMTS1 DNM1L PRDX2 LDHB EXOSC2 FAF1 UBE2O FXR1 NEMF ENAH ATP1A1 EIF1 PCBP1 PCBP2 | 4.96e-09 | 1149 | 280 | 31 | 35446349 |
| Pubmed | TMEM183A DZIP1L PEX1 TSNAX SRCAP ZFYVE1 PTPRC TJP2 ERP29 POGLUT2 FUBP3 STK24 FLNB EPB41L4B DNM1L TMEM183BP CUBN CCDC77 NCOA4 ANKRD6 TRIM5 KAT7 ORC4 SH3PXD2B FXR1 PAXBP1 LTN1 CEP295 ASXL2 ATP2B1 | 5.03e-09 | 1084 | 280 | 30 | 11544199 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DOCK11 RRBP1 USP9Y HP1BP3 IFIH1 CROCC2 FGB TJP2 PLEKHA5 COPS6 COPS5 SDCBP COL6A6 MTHFD1L NUMA1 RGS12 XIRP2 CTNNA1 GALNT5 ATP1A1 | 5.08e-09 | 497 | 280 | 20 | 36774506 |
| Pubmed | NES EIF4A3 HP1BP3 ITPR3 EFR3A AP2A1 GLB1 SUPT5H DDX18 SVIL SDCBP CAVIN2 FLNB LIMA1 NUMA1 PPM1B KAT7 MYOF FXR1 EGFR CAVIN1 SSH2 PCBP2 | 5.33e-09 | 660 | 280 | 23 | 32780723 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 NES EPPK1 EIF4A3 RRBP1 SRCAP HP1BP3 ITPR3 AP2A1 SUPT5H DDX18 SVIL PEX5 TJP2 UTP20 FUBP3 NIPBL HSPA9 KIFC1 FLNB LIMA1 NUMA1 FXR1 MYH14 CTNNA1 ATP1A1 PCBP1 PCBP2 ATP2B1 | 5.55e-09 | 1024 | 280 | 29 | 24711643 |
| Pubmed | DCAF1 NES INSRR RRBP1 ITPR3 SVIL TJP2 PLEKHA5 NIPBL HSPA9 CAVIN2 DYNC1I2 FLNB LIMA1 NUMA1 CTNNA1 PCBP1 | 7.19e-09 | 360 | 280 | 17 | 33111431 | |
| Pubmed | NES ZNF536 MPDZ RRBP1 ADCY9 GLB1 CIAPIN1 PEX5 TJP2 PLEKHA5 CHD6 ACBD3 PKN3 RPGRIP1L RGPD8 CHAF1A ICE1 NCOA4 PAIP1 UBE2O FXR1 MACO1 CEP295 CROCC | 8.15e-09 | 733 | 280 | 24 | 34672954 | |
| Pubmed | MTA2 EIF1B RRBP1 AP2A1 STRN4 COPS6 HSPA9 DYNC1I2 FLNB NUMA1 PRDX2 BCAR1 LDHB ORC4 ATP1A1 EIF1 PCBP1 PCBP2 | 8.30e-09 | 411 | 280 | 18 | 36652389 | |
| Pubmed | MTA2 NES EPPK1 PFAS HP1BP3 ITPR3 SUPT5H DDX18 TJP2 UTP20 FUBP3 NIPBL HSPA9 FLNB MTHFD1L NUMA1 UBE2O FXR1 MYH14 RCL1 CTNNA1 ATP1A1 | 2.12e-08 | 653 | 280 | 22 | 22586326 | |
| Pubmed | DDX59 EPPK1 EIF4A3 RRBP1 AP2A1 GLB1 FGF2 ERP29 POGLUT2 NIPBL HSPA9 SDCBP ALPI FLNB LIMA1 COL12A1 MTHFD1L CNTNAP1 NUMA1 DNM1L NCOA4 DDX55 EXOSC2 PAIP1 MYOF EGFR NEMF CAVIN1 ATP1A1 CROCC PCBP1 PCBP2 | 2.26e-08 | 1297 | 280 | 32 | 33545068 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | EDF1 DOCK11 RRBP1 ZFYVE1 PTK2 FBXO28 DDX18 CIAPIN1 TJP2 FUBP3 DYNC1I2 WASL EPB41L4B DDX55 EXOSC2 MYOF SH3PXD2B FXR1 MYH14 CAVIN1 ATP1A1 PCBP1 PCBP2 | 2.93e-08 | 724 | 280 | 23 | 36232890 |
| Pubmed | NES EPPK1 DOCK11 EIF4A3 MPDZ PEX14 HP1BP3 CIRBP AP2A1 FBXO28 TJP2 PKP2 DMD FUBP3 PKN3 WASL NUMA1 PRDX2 LDHB ARHGAP6 FAM13A MACO1 RCL1 ENAH CAVIN1 CTNNA1 | 3.42e-08 | 916 | 280 | 26 | 32203420 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 EPPK1 EIF4A3 TM9SF3 RRBP1 HP1BP3 ITPR3 AP2A1 DDX18 SVIL TJP2 PKP2 UTP20 PLEKHA5 C9 HSPA9 KIFC1 FLNB LIMA1 NUMA1 PRDX2 DDX55 LDHB EXOSC2 MYOF FXR1 EGFR RCL1 CAVIN1 CTNNA1 PCBP1 | 3.86e-08 | 1257 | 280 | 31 | 36526897 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ADCY9 EFR3A SVIL CIAPIN1 TJP2 PKP2 PLEKHA5 ACBD3 STK24 SDCBP CCS FLNB LIMA1 EPB41L4B SH3PXD2B EGFR CTNNA1 PCBP1 PCBP2 ATP2B1 | 4.25e-08 | 565 | 280 | 20 | 25468996 |
| Pubmed | DCAF1 MTA2 EIF4A3 MPDZ TSNAX RRBP1 PSMA8 HP1BP3 CIRBP AP2A1 SUPT5H COPS6 HSPA1L ACBD3 COPS5 FUBP3 HSPA9 MTHFD1L TRIM41 BAG4 PRDX2 LDHB EXOSC2 FAF1 ORC4 UBE2O FXR1 RCL1 CTNNA1 ATP1A1 PCBP1 PCBP2 | 4.40e-08 | 1335 | 280 | 32 | 29229926 | |
| Pubmed | SPTBN5 SEMA5B PKD1 DMD HSPA1L HSPA9 MXRA5 ZNF618 MYH14 ANKRD36 SSH2 CROCC | 4.47e-08 | 187 | 280 | 12 | 26460568 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | DCAF1 EIF4A3 PEX1 TSC2 SVIL DMD SDCBP PKN3 ADAMTS1 EPB41L4B NUMA1 TRIM5 TRIM3 PAXBP1 LTN1 | 4.61e-08 | 313 | 280 | 15 | 38270169 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MTA2 NES RRBP1 ITPR3 AP2A1 DDX18 SVIL TJP2 PKP2 HSPA9 FLNB LIMA1 RGPD8 NUMA1 PRDX2 BCAR1 NCOA4 FXR1 MYH14 PCBP1 PCBP2 | 4.81e-08 | 626 | 280 | 21 | 33644029 |
| Pubmed | PFAS COL22A1 ZC3H6 CIRBP STK10 CROCC2 SVIL EIF2B5 STRN4 FGB COL12A1 CHAF1A KAT6A DNM1L PRDX2 CCDC77 LDHB UBE2O EGFR ASXL2 SSH2 RASSF8 | 5.42e-08 | 689 | 280 | 22 | 36543142 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MTA2 EPPK1 EIF4A3 PFAS PKP2 HSPA1L FUBP3 HSPA9 DYNC1I2 FLNB LIMA1 NUMA1 PRDX2 LDHB UBE2O FXR1 ATP1A1 PIWIL3 | 7.95e-08 | 477 | 280 | 18 | 31300519 |
| Pubmed | FAM161B RRBP1 ANKRD27 PTPRC AP2A1 SUPT5H PKD1 PKP2 CHD6 ACBD3 COPS5 SDCBP FLNB EVC2 LAMA4 FAF1 MACO1 LRP1 ASXL2 PCBP2 | 8.80e-08 | 591 | 280 | 20 | 15231748 | |
| Pubmed | EPPK1 ADGRV1 ITIH1 STARD9 FBXO41 TJP2 TRIM46 MTHFD1L CNTNAP1 DNM1L GRIA2 GRIA4 PRDX2 FXR1 MPC1 PCBP1 ATP2B1 | 9.50e-08 | 430 | 280 | 17 | 32581705 | |
| Pubmed | 9.79e-08 | 70 | 280 | 8 | 20301607 | ||
| Pubmed | EIF4A3 STK26 PFAS RRBP1 ZC3H6 ITPR3 AP2A1 DDX18 SVIL PKP2 ACBD3 HSPA9 WASL LIMA1 NUMA1 PRDX2 LDHB EXOSC2 PPM1B MYOF FXR1 PAXBP1 MYH14 NEMF CTNNA1 ATP1A1 RASSF8 ATP1A3 PCBP1 PCBP2 | 1.11e-07 | 1247 | 280 | 30 | 27684187 | |
| Pubmed | 1.33e-07 | 16 | 280 | 5 | 17567809 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MTA2 EDF1 PEX14 PFAS TSNAX RRBP1 SRCAP HP1BP3 CIAPIN1 ACBD3 NIPBL HSPA9 SDCBP PKN3 LIMA1 NUMA1 DNM1L ICE1 PRDX2 LDHB UBE2O ENAH ATP1A1 PCBP1 PCBP2 | 1.92e-07 | 934 | 280 | 25 | 33916271 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 MTA2 ANKS6 TM9SF3 CDH23 TSC2 AP2A1 GLB1 SUPT5H EIF2B5 PLEKHA5 SPAG16 COPS6 HSPA1L COPS5 CFAP410 PKN3 DYNC1I2 LIMA1 RPGRIP1L WRN PRDX2 CCDC51 EXOSC2 ENAH CAVIN1 CTNNA1 RASSF8 ATP2B2 VPS53 | 3.76e-07 | 1321 | 280 | 30 | 27173435 |
| Pubmed | EPPK1 EIF4A3 RRBP1 ITPR3 CIRBP GLB1 DDX18 EIF2B5 TJP2 C9 FUBP3 HSPA9 FLNB GFM2 UBE2O FXR1 MYH14 CTNNA1 NUDCD1 ATP1A1 PCBP1 | 3.95e-07 | 711 | 280 | 21 | 33022573 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF224 RRBP1 STK10 PTPRC SVIL EIF2B5 TJP2 UTP20 NIPBL DYNC1I2 ALPI LIMA1 CHAF1A NUMA1 EXOSC2 MYOF PAXBP1 FAM13A ABCB9 EGFR CTNNA1 PCBP1 | 3.95e-07 | 774 | 280 | 22 | 15302935 |
| Pubmed | MTA2 EPPK1 EIF4A3 HP1BP3 ITPR3 DDX18 SVIL PYGM FUBP3 NIPBL HSPA9 FLNB CHAF1A NUMA1 LDHB EXOSC2 MYH14 CAVIN1 PCBP1 PCBP2 | 4.18e-07 | 652 | 280 | 20 | 31180492 | |
| Pubmed | MTA2 STK26 FYCO1 AP2A1 SUPT5H DDX18 COPS6 COPS5 FUBP3 HSPA9 KIFC1 NUMA1 DDX55 LDHB FAF1 FXR1 NEMF ENAH PCBP1 PCBP2 | 4.28e-07 | 653 | 280 | 20 | 33742100 | |
| Pubmed | MTA2 HP1BP3 CIRBP DDX18 A2ML1 TJP2 UTP20 FUBP3 CAVIN2 FLNB LIMA1 NUMA1 DDX55 LDHB EXOSC2 KAT7 FXR1 PAXBP1 MYH14 RCL1 CAVIN1 PCBP1 PCBP2 | 4.72e-07 | 847 | 280 | 23 | 35850772 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EDF1 SVIL CIAPIN1 PEX5 TJP2 HSPA9 DYNC1I2 WASL RPGRIP1L MTHFD1L CCDC77 EXOSC2 PAIP1 RGS12 SH3PXD2B MACO1 ENAH CEP295 AP4M1 ATP1A1 RASSF8 PCBP1 PCBP2 | 5.33e-07 | 853 | 280 | 23 | 28718761 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MTA2 B4GALT7 TM9SF3 TSC2 RRBP1 IGSF10 GLB1 FBXO28 SVIL CIAPIN1 UTP20 PLEKHA5 ERP29 POGLUT2 CFAP410 COL12A1 CNTNAP1 LAMA4 PRDX2 DDX55 MYOF EGFR LTN1 LRP1 LRP4 CTNNA1 ATP1A1 ATP2B1 | 5.63e-07 | 1201 | 280 | 28 | 35696571 |
| Pubmed | HP1BP3 SUPT5H DDX18 SVIL FGF2 UTP20 SDCBP RGPD8 NUMA1 EXOSC2 KAT7 FXR1 RCL1 NEMF | 6.11e-07 | 332 | 280 | 14 | 25693804 | |
| Pubmed | MTA2 EDF1 TMEM183A TM9SF3 PEX14 TSC2 ITPR3 EIF2B5 TJP2 ERP29 SLC30A9 FUBP3 ALPI STX8 FLNB MTHFD1L NUMA1 EXOSC2 GFM2 KAT7 MYOF MACO1 LTN1 LRP4 CAVIN1 CTNNA1 ATP1A1 EIF1 PCBP2 ATP2B1 VPS53 | 7.40e-07 | 1440 | 280 | 31 | 30833792 | |
| Pubmed | MTA2 EDF1 RRBP1 PSMA8 HP1BP3 CIRBP AP2A1 STARD9 DDX18 SVIL TJP2 PKP2 ERP29 FUBP3 HSPA9 STX8 WRN NUMA1 CCDC77 DDX55 TRIM3 FXR1 PAXBP1 MYH14 RCL1 NEMF CAVIN1 ATP1A1 PCBP1 PCBP2 | 8.11e-07 | 1371 | 280 | 30 | 36244648 | |
| Pubmed | DOCK11 MPDZ TSC2 AP2A1 STRN4 TJP2 PKP2 PLEKHA5 FUBP3 STK24 LIMA1 TRIM41 PARP8 CCDC77 CEP295 RASSF8 | 8.25e-07 | 446 | 280 | 16 | 24255178 | |
| Pubmed | MTA2 TSNAX AP2A1 SUPT5H EIF2B5 STRN4 PKP2 COPS6 COPS5 HSPA9 DYNC1I2 LIMA1 MTHFD1L NUMA1 INTS6 FXR1 ENAH LTN1 | 8.26e-07 | 560 | 280 | 18 | 35241646 | |
| Pubmed | MTA2 EDF1 EIF4A3 EIF1B PEX1 USP9Y PSMA8 HP1BP3 CIRBP AP2A1 GLB1 DDX18 CHD6 HSPA1L HSPA9 DYNC1I2 PRDX2 LDHB FAF1 UBE2O MYH14 ENAH ATP1A1 ATP1A3 EIF1 PCBP1 PCBP2 | 8.34e-07 | 1153 | 280 | 27 | 29845934 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTA2 NES EDF1 EIF4A3 SRCAP USP9Y ZC3H6 HP1BP3 CIRBP AP2A1 SUPT5H DDX18 CHD6 NIPBL NPTX2 ZNF618 PRDX2 DDX55 LDHB EXOSC2 INTS6 PAXBP1 RCL1 NEMF PCBP2 TNXB | 8.36e-07 | 1082 | 280 | 26 | 38697112 |
| Pubmed | MTA2 EIF4A3 STK26 TM9SF3 RRBP1 AP2A1 DDX18 CIAPIN1 ACBD3 HSPA9 DYNC1I2 FLNB RAP1GDS1 DNM1L LDHB LDHC FAF1 CTNNA1 ATP1A1 ATP1A3 PCBP1 PCBP2 ATP2B1 | 8.72e-07 | 878 | 280 | 23 | 37223481 | |
| Pubmed | HP1BP3 AP2A1 HSPA9 RAP1GDS1 SEPTIN5 CNTNAP1 DNM1L PRDX2 LDHB ATP1A1 ATP1A3 PCBP1 PCBP2 ATP2B1 ATP2B2 | 1.16e-06 | 403 | 280 | 15 | 30562941 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DCAF1 EPPK1 EIF4A3 PEX1 RRBP1 HP1BP3 GLB1 STRN4 PKP2 FGF2 PLEKHA5 HSPA1L HSPA9 DYNC1I2 ADAMTS1 PPM1B ENAH PCBP1 PCBP2 | 1.30e-06 | 639 | 280 | 19 | 23443559 |
| Pubmed | DCAF1 MTA2 ZNF536 PEX1 SRCAP ADCY9 JMJD6 DDX18 FGB PEX5 PKP2 TDRKH ADAMTS1 ZNF618 CHAF1A BAG4 KAT6A KAT7 INTS6 FXR1 LTN1 LRP1 LRP4 CEP295 CAVIN1 VPS53 | 1.48e-06 | 1116 | 280 | 26 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PEX14 TSNAX ADGRV1 RRBP1 GRHL2 PTK2 HP1BP3 STK10 KCNQ5 ABCC8 CHD6 COPS5 FLNB SEPTIN5 EPB41L4B KAT6A TMEM183BP BCAR1 FAF1 TATDN3 ARHGAP6 INTS6 FAM13A EGFR MYH14 NAXD NEMF ENAH LRP1 CROCC ATP2B1 | 1.49e-06 | 1489 | 280 | 31 | 28611215 |
| Pubmed | 1.56e-06 | 173 | 280 | 10 | 23979707 | ||
| Pubmed | EIF4A3 ADGRV1 RRBP1 ZFYVE1 ANKRD27 ADCY9 EFR3A SEMA5B MED12L FBXO41 PLEKHA5 ACAP3 ICE1 DDX55 UBE2O EFR3B LRP4 | 1.68e-06 | 529 | 280 | 17 | 14621295 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DOCK11 MPDZ PTK2 WASH6P A2ML1 NAV3 CHD6 STK24 MTUS2 CAVIN2 NPTX2 INTS6 FXR1 TENM4 NEMF KANK4 | 1.87e-06 | 475 | 280 | 16 | 31040226 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 MTA2 NES EIF4A3 CIRBP SUPT5H DDX18 UTP20 ERP29 HSPA9 KIFC1 FLNB MTHFD1L CHAF1A NUMA1 PRDX2 EXOSC2 KAT7 RCL1 CAVIN1 NUDCD1 ATP1A1 PCBP1 PCBP2 | 1.90e-06 | 989 | 280 | 24 | 36424410 |
| Pubmed | UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1. | 2.05e-06 | 4 | 280 | 3 | 36443833 | |
| Pubmed | 2.05e-06 | 4 | 280 | 3 | 19178537 | ||
| Pubmed | Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. | 2.05e-06 | 4 | 280 | 3 | 15140944 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES DOCK11 MPDZ TSC2 ANKRD27 KCNQ5 STARD9 SVIL TJP2 PKP2 PLEKHA5 LIMA1 PARP8 DNM1L BCAR1 RGS12 SH3PXD2B FXR1 FAM13A SSH2 RASSF8 ATP2B1 | 2.27e-06 | 861 | 280 | 22 | 36931259 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MTA2 EIF4A3 SLFN5 RRBP1 SRCAP HP1BP3 ITPR3 AP2A1 SUPT5H FBXO28 DDX18 UTP20 CHD6 FUBP3 NIPBL HSPA9 SDCBP CHAF1A WRN NUMA1 EXOSC2 KAT7 INTS6 PAXBP1 MACO1 ASXL2 PCBP1 PCBP2 | 2.39e-06 | 1294 | 280 | 28 | 30804502 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | MTA2 HP1BP3 CIRBP SUPT5H DDX18 STRN4 USH2A COPS5 DYNC1I2 FLNB LIMA1 NUMA1 CUBN LDHB LDHC EXOSC2 UBE2O MYH14 PCBP2 | 2.58e-06 | 670 | 280 | 19 | 22990118 |
| Pubmed | RRBP1 AP2A1 FGB TJP2 DMD HSPA9 DYNC1I2 FLNB LIMA1 PRDX2 MYH14 CAVIN1 CTNNA1 ATP1A1 PCBP1 PCBP2 | 2.64e-06 | 488 | 280 | 16 | 31324722 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 EIF4A3 STK26 RRBP1 AP2A1 FBXO28 C11orf68 SVIL STRN4 FGB PYGM COPS6 COPS5 NIPBL DYNC1I2 KIFC1 RGPD8 NUMA1 TRIM5 PAXBP1 CAVIN1 ASXL2 CTNNA1 TEN1 PCBP1 PCBP2 | 2.76e-06 | 1155 | 280 | 26 | 20360068 |
| Pubmed | ABCA4 PFAS TSNAX PYGM DMD HSPA9 DYNC1I2 LIMA1 PRDX2 LDHB MYH14 ATP1A1 ATP1A3 CROCC PCBP1 PCBP2 ATP2B1 | 2.97e-06 | 552 | 280 | 17 | 36293380 | |
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 3.05e-06 | 50 | 280 | 6 | 24769233 | |
| Pubmed | EIF4A3 PEX14 RRBP1 HP1BP3 CIRBP GLB1 DDX18 STRN4 DMD HSPA9 DYNC1I2 KIFC1 DNM1L PRDX2 LDHB EXOSC2 ENAH CTNNA1 EIF1 PCBP1 PCBP2 | 3.05e-06 | 809 | 280 | 21 | 32129710 | |
| Pubmed | 3.31e-06 | 29 | 280 | 5 | 15071553 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MTA2 EIF4A3 TM9SF3 RRBP1 PSMA8 ANKRD27 HP1BP3 AP2A1 JMJD6 DDX18 TJP2 CHD6 FUBP3 NIPBL HSPA9 MTHFD1L CHAF1A WRN NUMA1 DNM1L PRDX2 LDHB ORC4 FXR1 PAXBP1 RCL1 PCBP1 PCBP2 | 3.38e-06 | 1318 | 280 | 28 | 30463901 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | PEX1 PEX14 FYCO1 PKP2 UTP20 PLEKHA5 SLC30A9 POGLUT2 DYNC1I2 RAP1GDS1 ADAMTS1 SLC19A2 CCDC51 EXOSC2 TRIM3 FXR1 MYH14 MACO1 LTN1 ATP2B1 | 3.82e-06 | 754 | 280 | 20 | 33060197 |
| Pubmed | Large-scale cDNA transfection screening for genes related to cancer development and progression. | 4.21e-06 | 114 | 280 | 8 | 15498874 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PFAS SUPT5H HSPA1L HSPA9 DYNC1I2 FLNB MTHFD1L LDHB MYOF SH3PXD2B ATP1A1 PCBP1 PCBP2 | 5.12e-06 | 344 | 280 | 13 | 30333137 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | EPPK1 EFR3A AP2A1 DDX18 SVIL STK24 HSPA9 ALPI FLNB LIMA1 PRDX2 LDHB EGFR MYH14 ATP1A1 PCBP1 PCBP2 | 5.70e-06 | 580 | 280 | 17 | 35676659 |
| Pubmed | NES EIF4A3 A2ML1 DMD HSPA9 UBXN6 GRIA2 PRDX2 ANKRD6 PCBP1 PCBP2 | 5.91e-06 | 247 | 280 | 11 | 30713523 | |
| Pubmed | MPDZ ADCY9 EFR3A NAV3 VCAM1 CNTNAP1 RGS12 TRIM3 TENM4 EFR3B ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 6.17e-06 | 405 | 280 | 14 | 38187761 | |
| Pubmed | DCAF1 ZNF536 CSMD3 TENM2 KIAA0319 UNC5A JMJD6 STARD9 FBXO28 NAV3 CHD6 TENM4 ASXL2 CROCC | 6.52e-06 | 407 | 280 | 14 | 12693553 | |
| Pubmed | EIF4A3 TSC2 SVIL TJP2 PKP2 PLEKHA5 HSPA9 CCS LIMA1 RGS12 RASSF8 | 7.99e-06 | 255 | 280 | 11 | 15324660 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NES EPPK1 RRBP1 EFR3A PLEKHA5 KIFC1 FLNB LIMA1 MYOF EGFR ATP1A1 | 8.29e-06 | 256 | 280 | 11 | 33397691 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | CDC14C ZNF274 DOCK11 NCKAP5 SRCAP HP1BP3 CHD6 ALPI RAP1GDS1 COL12A1 EPB41L4B MYOF ATP2B1 | 9.10e-06 | 363 | 280 | 13 | 14691545 |
| Pubmed | MTA2 EIF4A3 PEX14 FYCO1 ANKRD27 ITPR3 PTPRC AP2A1 DDX18 PLEKHA5 ERP29 ACBD3 FUBP3 KIFC1 MTHFD1L DNM1L PSTPIP1 CCDC77 DDX55 LDHB FXR1 MYH14 PCBP1 PCBP2 ATP2B1 | 1.02e-05 | 1168 | 280 | 25 | 19946888 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EDF1 EPPK1 EIF4A3 EIF1B TSNAX RRBP1 CIRBP SUPT5H DDX18 C11orf68 UTP20 FUBP3 HSPA9 FLNB BAG4 UBE2O FXR1 EIF1 PCBP1 PCBP2 | 1.03e-05 | 807 | 280 | 20 | 22681889 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | RRBP1 AP2A1 DDX18 HSPA1L HSPA9 PKN3 LIMA1 DDX55 EXOSC2 KAT7 SH3PXD2B FXR1 NEMF PCBP2 VPS53 | 1.11e-05 | 486 | 280 | 15 | 30940648 |
| Pubmed | DCAF1 MPDZ PFAS RRBP1 ADCY9 HP1BP3 ITPR3 EFR3A GLB1 DDX18 PLEKHA5 ERP29 SLC30A9 HSPA1L ACBD3 HSPA9 STX8 MTHFD1L BAG4 CCDC77 UBE2O DNAJC17 PAXBP1 EGFR MACO1 RCL1 EFR3B CTNNA1 ATP2B1 | 1.15e-05 | 1487 | 280 | 29 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 NACA2 ANKS6 EPPK1 PFAS TSC2 FYCO1 SRCAP ADCY7 ADCY9 ITPR3 STK10 AP2A1 PKD1 STRN4 PKN3 MTHFD1L KAT6A ICE1 CCDC142 HDDC3 MYOF SH3PXD2B LRP4 | 1.22e-05 | 1105 | 280 | 24 | 35748872 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | EPPK1 EIF4A3 SUPT5H HSPA9 FLNB NUMA1 LRP1 CTNNA1 ATP1A1 PCBP1 | 1.26e-05 | 219 | 280 | 10 | 31353912 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TM9SF3 PEX1 PEX14 TSC2 RRBP1 ADCY9 ITPR3 SPTBN5 FBXO28 DDX18 STRN4 PEX5 SLC30A9 ACBD3 FUBP3 HSPA9 TDRKH RPGRIP1L RGPD8 MTHFD1L DNM1L CCDC77 DDX55 CCDC51 GFM2 FXR1 MACO1 RCL1 ATP1A1 | 1.28e-05 | 1496 | 280 | 29 | 32877691 |
| Pubmed | EDF1 B4GALT7 TM9SF3 MPDZ EFR3A CIRBP FBXO28 STRN4 UTP20 CHD6 NIPBL SDCBP KIFC1 TDRKH SEPTIN5 MTHFD1L CHAF1A WRN ICE1 DDX55 EXOSC2 ORC4 MYOF INTS6 PAXBP1 MACO1 RCL1 LTN1 CROCC | 1.30e-05 | 1497 | 280 | 29 | 31527615 | |
| Pubmed | MPDZ RRBP1 SVIL TJP2 FUBP3 HSPA9 FLNB LIMA1 BAG4 FXR1 CTNNA1 | 1.56e-05 | 274 | 280 | 11 | 34244482 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 MTA2 TM9SF3 MPDZ PFAS ITPR3 AP2A1 SUPT5H TJP2 DMD ACBD3 FUBP3 FLNB MTHFD1L DNM1L UBE2O FXR1 MACO1 LTN1 LRP1 CTNNA1 ATP2B1 | 1.57e-05 | 974 | 280 | 22 | 28675297 |
| Pubmed | 1.76e-05 | 7 | 280 | 3 | 20058854 | ||
| Pubmed | 1.76e-05 | 7 | 280 | 3 | 10330270 | ||
| Pubmed | 1.76e-05 | 7 | 280 | 3 | 15048729 | ||
| Interaction | KCTD13 interactions | MTA2 NES STK26 DAPK1 RRBP1 HP1BP3 AP2A1 SVIL STRN4 FBXO41 TJP2 PKP2 PLEKHA5 DMD HSPA1L MTUS2 HSPA9 SDCBP CNTN2 TRIM46 FLNB WASL LIMA1 RAP1GDS1 SEPTIN5 EPB41L4B CNTNAP1 DNM1L GRIA2 PRDX2 LDHB TRIM3 FAF1 KAT7 UBE2O FXR1 TENM4 MYH14 CTNNA1 SSH2 ATP1A1 ATP1A3 CROCC PCBP1 ATP2B1 ATP2B2 | 2.58e-08 | 1394 | 277 | 46 | int:KCTD13 |
| Interaction | LRRC31 interactions | DCAF1 RRBP1 ITPR3 UTP20 FLNB CNTNAP1 WRN NUMA1 ICE1 MYOF EGFR MYH14 LTN1 ATP1A1 | 1.00e-06 | 205 | 277 | 14 | int:LRRC31 |
| Interaction | EFTUD2 interactions | MTA2 EDF1 DDX59 EIF4A3 PFAS TSNAX RRBP1 HP1BP3 CIRBP AP2A1 JMJD6 SUPT5H DDX18 COPS6 ACBD3 COPS5 NIPBL HSPA9 SDCBP VCAM1 DYNC1I2 FLNB MTHFD1L CHAF1A NUMA1 PRDX2 DDX55 CCDC51 LDHB EXOSC2 ORC4 UBE2O FXR1 DNAJC17 PAXBP1 EGFR NEMF CAVIN1 ASXL2 CTNNA1 ATP1A1 PCBP1 PCBP2 | 1.40e-06 | 1449 | 277 | 43 | int:EFTUD2 |
| Interaction | HEATR4 interactions | 2.57e-06 | 3 | 277 | 3 | int:HEATR4 | |
| Interaction | RHOA interactions | EPPK1 EIF4A3 TM9SF3 RRBP1 TENM2 ADCY9 ITPR3 EFR3A STK10 GLB1 DDX18 FGB TJP2 PKP2 UTP20 PLEKHA5 SLC30A9 ACBD3 FUBP3 MTUS2 SDCBP PKN3 STX8 LIMA1 RAP1GDS1 CNTNAP1 PRDX2 HDDC3 MYOF FXR1 EGFR MACO1 EFR3B CAVIN1 CTNNA1 ATP1A1 ATP2B1 | 3.44e-06 | 1199 | 277 | 37 | int:RHOA |
| Interaction | PTPN1 interactions | TMEM183A INSRR PEX1 PEX14 TSNAX RRBP1 ADCY9 ITPR3 PEX5 ACBD3 COPS5 DYNC1I2 TDRKH EVC2 RGPD8 DNM1L GRIA2 BCAR1 EGFR MACO1 LTN1 CEP295 CAVIN1 ATP1A1 | 6.29e-06 | 625 | 277 | 24 | int:PTPN1 |
| Interaction | LYN interactions | CDH23 TSNAX ADCY9 PTK2 EFR3A STK10 PTPRC FBXO28 DDX18 SVIL PKP2 PLEKHA5 DMD FUBP3 HSPA9 LIMA1 EPB41L4B BCAR1 DDX55 EGFR EFR3B CTNNA1 ATP1A1 RASSF8 ATP2B1 IL7R | 7.65e-06 | 720 | 277 | 26 | int:LYN |
| Interaction | TNIP1 interactions | MTA2 EPPK1 EIF4A3 RRBP1 HP1BP3 ITPR3 AP2A1 GLB1 DDX18 SVIL A2ML1 PKP2 UTP20 DMD HSPA9 SDCBP KIFC1 NDNF FLNB LIMA1 EPB41L4B NUMA1 LAMA4 PRDX2 BCAR1 DDX55 LDHB FAF1 HDDC3 FXR1 MYH14 CAVIN1 CTNNA1 ATP1A1 PCBP1 PCBP2 | 1.20e-05 | 1217 | 277 | 36 | int:TNIP1 |
| Interaction | YWHAZ interactions | B4GALT7 DOCK11 PFAS TSC2 ANKRD27 KCNQ5 STARD9 SVIL TJP2 PKP2 PLEKHA5 COPS5 HSPA9 CFAP410 VCAM1 LIMA1 RPGRIP1L COL6A6 CHAF1A PARP8 KAT6A DNM1L PRDX2 BCAR1 LDHB RGS12 TRIM3 FAF1 FAM13A EGFR MACO1 ENAH ASXL2 SSH2 ATP1A1 RASSF8 ATP2B1 ATP2B2 | 1.22e-05 | 1319 | 277 | 38 | int:YWHAZ |
| Interaction | RHOB interactions | EPPK1 DOCK11 TM9SF3 TSC2 TENM2 ADCY9 EFR3A STK10 DDX18 TJP2 PKP2 UTP20 PLEKHA5 HSPA9 SDCBP PKN3 STX8 RAP1GDS1 PRDX2 MYOF EGFR EFR3B LRP4 CAVIN1 CTNNA1 ATP1A1 RASSF8 ATP2B1 | 1.48e-05 | 840 | 277 | 28 | int:RHOB |
| Interaction | FBXO22 interactions | DOCK11 RRBP1 USP9Y HP1BP3 IFIH1 CROCC2 FGB TJP2 PLEKHA5 COPS6 COPS5 SDCBP COL6A6 MTHFD1L NUMA1 BCAR1 RGS12 XIRP2 CTNNA1 GALNT5 ATP1A1 | 2.02e-05 | 540 | 277 | 21 | int:FBXO22 |
| Interaction | KRT18 interactions | NES EPPK1 ITPR3 SVIL PKD1 PKP2 USH2A VCAM1 FLNB RPGRIP1L CCDC77 PPM1B UBE2O FXR1 EGFR MACO1 CAVIN1 CTNNA1 | 2.19e-05 | 419 | 277 | 18 | int:KRT18 |
| Interaction | VCL interactions | MPDZ PFAS PTK2 SVIL PKD1 PLEKHA5 STK24 HSPA9 VCAM1 LIMA1 RAP1GDS1 BCAR1 EGFR ENAH CTNNA1 | 2.29e-05 | 305 | 277 | 15 | int:VCL |
| Interaction | YWHAE interactions | DCAF1 MTA2 DOCK11 EIF4A3 STK26 TSC2 TSNAX ANKRD27 KCNQ5 SVIL TJP2 PKP2 PLEKHA5 CFAP410 VCAM1 DYNC1I2 LIMA1 RAP1GDS1 RPGRIP1L CHAF1A PARP8 DNM1L BCAR1 LDHB RGS12 FAF1 PPM1B UBE2O FAM13A CAVIN1 ASXL2 SSH2 ATP1A1 RASSF8 PCBP1 IL7R | 2.36e-05 | 1256 | 277 | 36 | int:YWHAE |
| Interaction | PEX3 interactions | EPPK1 PEX1 PEX14 ITPR3 PEX5 PKP2 ALPI TDRKH DNM1L PCBP1 ATP2B1 | 2.57e-05 | 171 | 277 | 11 | int:PEX3 |
| Interaction | NUPR1 interactions | NES EIF4A3 HP1BP3 ITPR3 EFR3A AP2A1 GLB1 SUPT5H DDX18 SVIL COPS5 SDCBP CAVIN2 FLNB LIMA1 NUMA1 PPM1B KAT7 MYOF FXR1 EGFR CAVIN1 SSH2 PCBP2 | 2.70e-05 | 683 | 277 | 24 | int:NUPR1 |
| Interaction | EZR interactions | B4GALT7 PTK2 STK10 PTPRC AP2A1 DDX18 SVIL PLEKHA5 VCAM1 DYNC1I2 LIMA1 RAP1GDS1 DNM1L EGFR NEMF ENAH CTNNA1 ATP1A1 CROCC PCBP2 ATP2B1 | 2.86e-05 | 553 | 277 | 21 | int:EZR |
| Interaction | CACNG3 interactions | 3.14e-05 | 14 | 277 | 4 | int:CACNG3 | |
| Interaction | MAPRE1 interactions | EDF1 EIF4A3 RRBP1 HP1BP3 IGSF10 DDX18 SVIL NAV3 PLEKHA5 COPS5 MTUS2 VCAM1 DYNC1I2 FLNB LIMA1 NUMA1 CCDC77 FXR1 LRP1 CTNNA1 | 3.16e-05 | 514 | 277 | 20 | int:MAPRE1 |
| Interaction | PPIA interactions | MTA2 NES EIF4A3 PEX14 ANKRD36C RRBP1 IFIH1 STK10 SUPT5H STARD9 CIAPIN1 PLEKHA5 DMD ACBD3 COPS5 FUBP3 SDCBP VCAM1 PKN3 KIFC1 EPB41L4B DNM1L LDHB SH3PXD2B DNAJC17 MACO1 ASXL2 ANKRD36 | 4.00e-05 | 888 | 277 | 28 | int:PPIA |
| Interaction | MYH9 interactions | DCAF1 MTA2 EIF4A3 ITPR3 AP2A1 SVIL PEX5 COPS6 HSPA1L ACBD3 COPS5 HSPA9 VCAM1 DYNC1I2 FLNB LIMA1 MTHFD1L GRIA4 FAF1 FXR1 EGFR MYH14 LTN1 SSH2 ATP1A1 | 4.73e-05 | 754 | 277 | 25 | int:MYH9 |
| Interaction | OBSL1 interactions | MTA2 NES EPPK1 EIF4A3 SRCAP HP1BP3 ITPR3 CIRBP AP2A1 GLB1 SEMA5B SUPT5H CROCC2 DDX18 TJP2 UTP20 FUBP3 NIPBL HSPA9 FLNB LIMA1 NUMA1 DDX55 NEMF CAVIN1 CTNNA1 PCBP1 PCBP2 | 5.25e-05 | 902 | 277 | 28 | int:OBSL1 |
| Interaction | CAPRIN2 interactions | 5.58e-05 | 16 | 277 | 4 | int:CAPRIN2 | |
| Interaction | BAP1 interactions | MTA2 NES EPPK1 STK26 MPDZ PFAS TSNAX ITPR3 CIRBP AP2A1 SVIL ERP29 COPS6 HSPA1L ACBD3 HSPA9 DYNC1I2 FLNB LIMA1 ADAMTS1 BAG4 DNM1L PRDX2 LDHB EXOSC2 FAF1 UBE2O FXR1 EGFR NEMF ENAH ASXL2 ATP1A1 EIF1 PCBP1 PCBP2 | 6.02e-05 | 1314 | 277 | 36 | int:BAP1 |
| Interaction | CDH1 interactions | ADCY9 PTK2 EFR3A SVIL CIAPIN1 PKD1 TJP2 PKP2 PLEKHA5 ACBD3 STK24 HSPA9 SDCBP CCS FLNB LIMA1 EPB41L4B CHAF1A BCAR1 SH3PXD2B EGFR CTNNA1 PCBP1 PCBP2 ATP2B1 | 6.36e-05 | 768 | 277 | 25 | int:CDH1 |
| Interaction | HMGA1 interactions | MTA2 SRCAP HP1BP3 JMJD6 SUPT5H ABCC8 STRN4 CHAF1A KAT6A NUMA1 KAT7 UBE2O EGFR KCNQ4 AP4M1 PCBP1 PCBP2 | 7.50e-05 | 419 | 277 | 17 | int:HMGA1 |
| Interaction | TLN1 interactions | PTK2 PKD1 FGB VCAM1 NUMA1 DNM1L BCAR1 FAF1 HDDC3 EGFR KANK4 ATP1A1 PCBP1 | 7.92e-05 | 264 | 277 | 13 | int:TLN1 |
| Interaction | RAB11A interactions | DAPK1 RRBP1 ADCY9 ITPR3 EFR3A STK10 DDX18 PKP2 PLEKHA5 HSPA1L ACBD3 COPS5 STK24 SDCBP UBXN6 DNM1L GRIA2 EGFR MACO1 EFR3B LRP1 LRP4 CAVIN1 ATP1A1 ATP2B1 VPS53 | 8.48e-05 | 830 | 277 | 26 | int:RAB11A |
| Interaction | PKD1 interactions | 8.53e-05 | 53 | 277 | 6 | int:PKD1 | |
| Interaction | BICD2 interactions | EDF1 FAM161B SVIL CIAPIN1 TJP2 DYNC1I2 WASL RGPD8 LDHB EXOSC2 PAIP1 SH3PXD2B MACO1 ENAH CAVIN1 PCBP1 PCBP2 | 9.17e-05 | 426 | 277 | 17 | int:BICD2 |
| Interaction | SIRT7 interactions | DCAF1 MTA2 NES EPPK1 PFAS HP1BP3 ITPR3 SUPT5H DDX18 TJP2 UTP20 COPS5 FUBP3 NIPBL HSPA9 FLNB MTHFD1L NUMA1 UBE2O FXR1 MYH14 RCL1 CTNNA1 ATP1A1 | 1.03e-04 | 744 | 277 | 24 | int:SIRT7 |
| Interaction | RAN interactions | MTA2 EIF4A3 TSNAX IGSF10 HSPA9 VCAM1 KIFC1 FLNB RGPD8 NUMA1 C10orf90 PRDX2 BCAR1 EXOSC2 UBE2O EGFR ASXL2 PCBP1 | 1.10e-04 | 475 | 277 | 18 | int:RAN |
| Interaction | LAMP2 interactions | STK26 DAPK1 TSC2 FYCO1 ADCY9 HP1BP3 ITPR3 EFR3A STK10 KCNQ5 AP2A1 PKP2 SLC30A9 ACBD3 STX8 MACO1 EFR3B AP4M1 ATP1A1 ATP2B1 VPS53 | 1.13e-04 | 609 | 277 | 21 | int:LAMP2 |
| Interaction | NCKIPSD interactions | 1.19e-04 | 137 | 277 | 9 | int:NCKIPSD | |
| Interaction | SLC6A4 interactions | EPPK1 ADGRV1 ITIH1 STARD9 FBXO41 TJP2 TRIM46 MTHFD1L CNTNAP1 DNM1L GRIA2 GRIA4 PRDX2 FXR1 MPC1 PCBP1 ATP2B1 | 1.25e-04 | 437 | 277 | 17 | int:SLC6A4 |
| Interaction | CFAP97 interactions | 1.29e-04 | 57 | 277 | 6 | int:CFAP97 | |
| Interaction | KIF20A interactions | NES EPPK1 NUP210L EIF4A3 FAM161B USP9Y EFR3A IFIH1 AP2A1 GLB1 DDX18 SVIL EIF2B5 NAV3 TJP2 PKP2 PKN3 FLNB FBLN7 LIMA1 RGPD8 NUMA1 RGS12 TRIM5 FXR1 PAXBP1 MYH14 CAVIN1 SSH2 PCBP1 | 1.30e-04 | 1052 | 277 | 30 | int:KIF20A |
| Interaction | PRNP interactions | PFAS COL22A1 ZC3H6 CIRBP STK10 AP2A1 CROCC2 C11orf68 SVIL EIF2B5 STRN4 FGB TJP2 DMD COPS6 COL12A1 CHAF1A KAT6A DNM1L PRDX2 CCDC77 LDHB PAIP1 PPM1B UBE2O ASXL2 SSH2 ATP1A1 RASSF8 ATP1A3 ATP2B1 ATP2B2 | 1.36e-04 | 1158 | 277 | 32 | int:PRNP |
| Interaction | HSP90AA1 interactions | MTA2 NES DDX59 INSRR DAPK1 RRBP1 ITIH1 PTK2 HP1BP3 NOD1 FBXO10 SUPT5H FBXO28 SVIL COPS6 HSPA1L COPS5 NIPBL HSPA9 VCAM1 PKN3 WASL COL12A1 TRIM41 BAG4 NUMA1 DDX55 FAF1 EGFR KCNQ4 LRP1 ASXL2 ATP1A1 PCBP1 | 1.37e-04 | 1263 | 277 | 34 | int:HSP90AA1 |
| Interaction | EPB41L4A interactions | 1.40e-04 | 140 | 277 | 9 | int:EPB41L4A | |
| Interaction | FGD5 interactions | RRBP1 JMJD6 SVIL TJP2 HSPA9 FLNB LIMA1 PRDX2 LDHB EGFR MYH14 | 1.44e-04 | 207 | 277 | 11 | int:FGD5 |
| Interaction | RUVBL1 interactions | MTA2 SRCAP FBXO10 HSPA1L COPS5 NIPBL DYNC1I2 CHAF1A UBXN6 NUMA1 DNM1L PSTPIP1 FAF1 UBE2O EGFR MYH14 ASXL2 ATP1A1 PCBP1 PCBP2 | 1.47e-04 | 575 | 277 | 20 | int:RUVBL1 |
| Interaction | PXMP2 interactions | PEX1 PEX14 RRBP1 ADCY9 ITPR3 PEX5 SLC30A9 ACBD3 TDRKH UBXN6 DNM1L MACO1 ATP2B1 | 1.48e-04 | 281 | 277 | 13 | int:PXMP2 |
| Interaction | RAC2 interactions | DOCK11 TM9SF3 RRBP1 ADCY9 ITPR3 EFR3A DDX18 UTP20 PLEKHA5 ACBD3 SDCBP VCAM1 STX8 RAP1GDS1 PRDX2 MYOF EGFR MACO1 CAVIN1 CTNNA1 ATP1A1 ATP2B1 | 1.70e-04 | 674 | 277 | 22 | int:RAC2 |
| Interaction | GSK3B interactions | MPDZ PFAS TSC2 RRBP1 PTK2 DDX18 EIF2B5 PEX5 PLEKHA5 CHD6 COPS5 HSPA9 DYNC1I2 UBXN6 DNM1L GRIA2 C10orf90 BCAR1 ANKRD6 LDHB MYOF UBE2O FXR1 CAVIN1 CTNNA1 RASSF8 | 1.73e-04 | 868 | 277 | 26 | int:GSK3B |
| Interaction | PINK1 interactions | MTA2 NES EPPK1 EIF4A3 PFAS A2ML1 FGB PKP2 HSPA1L FUBP3 HSPA9 DYNC1I2 FLNB LIMA1 NUMA1 DNM1L PRDX2 LDHB UBE2O FXR1 ATP1A1 PIWIL3 | 1.88e-04 | 679 | 277 | 22 | int:PINK1 |
| Interaction | CXADR interactions | ANKS6 ADCY9 EFR3A TJP2 PKP2 PLEKHA5 ACBD3 EPB41L4B UBXN6 EGFR MACO1 EFR3B ATP1A1 RASSF8 ATP2B1 | 1.94e-04 | 369 | 277 | 15 | int:CXADR |
| Interaction | CTCFL interactions | 2.06e-04 | 62 | 277 | 6 | int:CTCFL | |
| Interaction | GAN interactions | SPTBN5 SEMA5B PKD1 DMD HSPA1L HSPA9 MXRA5 ZNF618 MYH14 ANKRD36 SSH2 CROCC | 2.10e-04 | 253 | 277 | 12 | int:GAN |
| Interaction | ESF1 interactions | EIF4A3 DDX18 ADAMTS1 CHAF1A KAT6A DNAJC17 EGFR RCL1 CAVIN1 PCBP1 | 2.20e-04 | 182 | 277 | 10 | int:ESF1 |
| Interaction | AFDN interactions | ADCY9 EFR3A TJP2 PKP2 PLEKHA5 MTUS2 VCAM1 LIMA1 FXR1 EGFR EFR3B CTNNA1 RASSF8 ATP2B1 | 2.24e-04 | 333 | 277 | 14 | int:AFDN |
| GeneFamily | Fibronectin type III domain containing | 2.74e-04 | 160 | 188 | 8 | 555 | |
| GeneFamily | AAA ATPases|Peroxins | 5.61e-04 | 16 | 188 | 3 | 957 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 6.37e-04 | 4 | 188 | 2 | 1244 | |
| GeneFamily | Cavins | 6.37e-04 | 4 | 188 | 2 | 1326 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 6.37e-04 | 4 | 188 | 2 | 1200 | |
| GeneFamily | DEAD-box helicases | 9.31e-04 | 42 | 188 | 4 | 499 | |
| GeneFamily | Ankyrin repeat domain containing | ANKS6 DAPK1 ANKRD36C ANKS4B ANKRD27 ACAP3 ANKRD6 KANK4 ANKRD36 | 9.95e-04 | 242 | 188 | 9 | 403 |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.11e-03 | 20 | 188 | 3 | 1371 | |
| GeneFamily | Actins|Deafness associated genes | 1.17e-03 | 113 | 188 | 6 | 1152 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 2.18e-03 | 7 | 188 | 2 | 1208 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 2.99e-03 | 28 | 188 | 3 | 745 | |
| GeneFamily | COP9 signalosome | 3.69e-03 | 9 | 188 | 2 | 932 | |
| GeneFamily | ATPases Ca2+ transporting | 3.69e-03 | 9 | 188 | 2 | 1209 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 4.58e-03 | 10 | 188 | 2 | 53 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PEX14 DAPK1 ADCY9 PTK2 EFR3A STK10 NAV3 TJP2 FGF2 UTP20 DMD ACBD3 STK24 NIPBL FLNB KAT6A WRN PAIP1 PPM1B MYOF FXR1 EGFR LTN1 ATP2B1 IL7R | 5.40e-06 | 856 | 278 | 25 | M4500 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | CYP2J2 MPDZ RRBP1 TENM2 ADCY9 IGSF10 IFIH1 STK10 PLEKHA5 PYGM DMD CAVIN2 VCAM1 FLNB ADAMTS1 EPB41L4B GRIA2 ARHGAP6 ENAH LRP4 ASTN1 EIF1 | 1.03e-05 | 721 | 278 | 22 | M1999 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 ADGRV1 CSMD3 NAV3 DMD USH2A CNTN2 COL12A1 TENM4 XIRP2 | 2.60e-08 | 184 | 280 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 ADGRV1 CSMD3 NAV3 DMD USH2A CNTN2 COL12A1 TENM4 XIRP2 | 2.60e-08 | 184 | 280 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 ADGRV1 CSMD3 NAV3 DMD USH2A CNTN2 COL12A1 TENM4 XIRP2 | 2.60e-08 | 184 | 280 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | NES NDNF MXRA5 COL12A1 GRIA4 TENM4 EGFR ENAH LRP1 KANK4 LRP4 | 4.73e-08 | 195 | 280 | 11 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | NCKAP5 TENM2 VCAM1 MXRA5 COL12A1 EPB41L4B LAMA4 TENM4 EGFR ENAH LRP1 | 5.25e-08 | 197 | 280 | 11 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | NCKAP5 TENM2 VCAM1 MXRA5 COL12A1 EPB41L4B LAMA4 TENM4 EGFR ENAH LRP1 | 5.25e-08 | 197 | 280 | 11 | b9745e382baa2725dfcae060701fb53f6c8a31fa |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | NCKAP5 TENM2 VCAM1 MXRA5 COL12A1 EPB41L4B LAMA4 TENM4 EGFR ENAH LRP1 | 5.25e-08 | 197 | 280 | 11 | 1baffd087ca194a7355fefbb3bf67befb14fe2de |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DAPK1 ADGRV1 RRBP1 GRHL2 NDNF CCDC141 EGFR MYH14 GALNT5 ATP1A1 PLAAT5 | 5.25e-08 | 197 | 280 | 11 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.01e-08 | 159 | 280 | 10 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-07 | 131 | 280 | 9 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADGRV1 RRBP1 GRHL2 TENM4 FAM13A EGFR MYH14 KANK4 GALNT5 ATP1A1 | 2.12e-07 | 179 | 280 | 10 | fd2cbee532e7b44113410dca82aec7db1a7fb69f |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RRBP1 IGSF10 PLEKHA5 FBLN7 LIMA1 COL12A1 COL6A6 EGFR LRP1 TNXB | 4.06e-07 | 192 | 280 | 10 | 11088878043a6ff95ba1970361256a82e434b80a |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-07 | 193 | 280 | 10 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EPSTI1 CSMD3 SVIL MXRA5 COL12A1 COL6A6 ADAMTS1 CCDC141 MYOF CAVIN1 | 4.26e-07 | 193 | 280 | 10 | cd45118ced91b10baed3b1068d4673ec99824b86 |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | NES MPDZ COL22A1 NAV3 FGF2 ADAMTS1 LAMA4 C10orf90 CAVIN1 RASSF8 | 4.26e-07 | 193 | 280 | 10 | 6be11fef87af04ee7a3cc223882ccd4077caded9 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | NCKAP5 TENM2 SVIL ALPK3 PKP2 PLEKHA5 DMD MTUS2 CCDC141 XIRP2 | 4.68e-07 | 195 | 280 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-07 | 195 | 280 | 10 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 TENM2 KCNQ5 PKD1 PLEKHA5 MTUS2 GRIA2 ANKRD36 ATP2B1 ATP2B2 | 4.91e-07 | 196 | 280 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | RRBP1 IGSF10 VCAM1 MXRA5 COL6A6 ADAMTS1 LAMA4 MYOF LRP1 TNXB | 5.14e-07 | 197 | 280 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 TENM2 KCNQ5 PKD1 PLEKHA5 MTUS2 GRIA2 ATP1A3 ATP2B1 ATP2B2 | 5.38e-07 | 198 | 280 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 TENM2 KCNQ5 PLEKHA5 MTUS2 GRIA2 ANKRD36 ATP1A3 ATP2B1 ATP2B2 | 5.38e-07 | 198 | 280 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 TENM2 KCNQ5 PLEKHA5 MTUS2 GRIA2 TENM4 ATP1A3 ATP2B1 ATP2B2 | 5.38e-07 | 198 | 280 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 KCNQ5 PLEKHA5 MTUS2 DYNC1I2 GRIA2 ANKRD36 ATP1A3 ATP2B1 ATP2B2 | 5.38e-07 | 198 | 280 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CSMD3 TENM2 KCNQ5 PKD1 PLEKHA5 MTUS2 ANKRD36 ATP1A3 ATP2B1 ATP2B2 | 5.90e-07 | 200 | 280 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-07 | 157 | 280 | 9 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 179 | 280 | 9 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-06 | 181 | 280 | 9 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.38e-06 | 182 | 280 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-06 | 182 | 280 | 9 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 184 | 280 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-06 | 184 | 280 | 9 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.72e-06 | 185 | 280 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 186 | 280 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 186 | 280 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 186 | 280 | 9 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.97e-06 | 187 | 280 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-06 | 188 | 280 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.11e-06 | 188 | 280 | 9 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.11e-06 | 188 | 280 | 9 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.39e-06 | 190 | 280 | 9 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 191 | 280 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 193 | 280 | 9 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.85e-06 | 193 | 280 | 9 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | SIGLEC8 MGAT4A ANKRD36C ALPK3 PKP2 MTHFD1L ZNF618 ANKRD36 RASSF8 | 3.85e-06 | 193 | 280 | 9 | 198552810dcac8d0ca63a78badd6702b49ff6edf |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-06 | 193 | 280 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-06 | 195 | 280 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.19e-06 | 195 | 280 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-06 | 195 | 280 | 9 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.36e-06 | 196 | 280 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 196 | 280 | 9 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-06 | 197 | 280 | 9 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-06 | 197 | 280 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | lymphoid-T_cell|lymphoid / Lineage, cell class and subclass | 4.74e-06 | 198 | 280 | 9 | 41573038b34803f664a7cb5a7d05b8afdff55b58 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-06 | 198 | 280 | 9 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.74e-06 | 198 | 280 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-06 | 198 | 280 | 9 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-06 | 198 | 280 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-06 | 198 | 280 | 9 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.94e-06 | 199 | 280 | 9 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.94e-06 | 199 | 280 | 9 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.94e-06 | 199 | 280 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-06 | 199 | 280 | 9 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 150 | 280 | 8 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-06 | 200 | 280 | 9 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-06 | 200 | 280 | 9 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.14e-06 | 200 | 280 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-06 | 200 | 280 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-06 | 158 | 280 | 8 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.79e-06 | 162 | 280 | 8 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.62e-06 | 164 | 280 | 8 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 165 | 280 | 8 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-05 | 169 | 280 | 8 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 175 | 280 | 8 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-05 | 176 | 280 | 8 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 177 | 280 | 8 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 177 | 280 | 8 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 177 | 280 | 8 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 1.67e-05 | 177 | 280 | 8 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 178 | 280 | 8 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.74e-05 | 178 | 280 | 8 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 178 | 280 | 8 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 179 | 280 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.81e-05 | 179 | 280 | 8 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-05 | 179 | 280 | 8 | d5b9c610c1519804b1753fed1b505293ea590867 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 130 | 280 | 7 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.89e-05 | 180 | 280 | 8 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 181 | 280 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-05 | 183 | 280 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.13e-05 | 183 | 280 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 184 | 280 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.21e-05 | 184 | 280 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.21e-05 | 184 | 280 | 8 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 184 | 280 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | AT1_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-05 | 90 | 280 | 6 | 6cbf30dd3992d8ccfaa74ad9781b9f8735f1ef69 | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | SPTBN5 NOD1 FBXO41 GIMAP6 CFAP410 HTR1F BAG4 EXOSC2 RGS12 ABCB9 MYH14 ATP1A3 | 6.34e-06 | 199 | 277 | 12 | 3228_UP |
| Drug | AC1L1KMJ | COL22A1 PTK2 SPTBN5 JMJD6 PKD1 TJP2 VCAM1 PKN3 ALPI WASL LIMA1 COL12A1 LDHAL6B LAMA4 DNM1L BCAR1 LDHB LDHC ENAH | 6.66e-06 | 476 | 277 | 19 | CID000030956 |
| Drug | verapamil | ABCA4 CYP2J2 ADCY7 ADCY9 ITPR3 KCNQ5 PKD1 FGF2 PKN3 ALPI PKD1L3 ABCB9 EGFR MYH14 KCNQ4 ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 1.00e-05 | 490 | 277 | 19 | CID000002520 |
| Drug | AC1L9732 | 1.09e-05 | 114 | 277 | 9 | CID000439300 | |
| Drug | spirobishexahydropyrimidine | 1.75e-05 | 5 | 277 | 3 | CID000100750 | |
| Drug | AC1O5TJF | 1.75e-05 | 5 | 277 | 3 | CID006440410 | |
| Drug | 1,4-diethoxybutane | 1.75e-05 | 5 | 277 | 3 | CID000232578 | |
| Drug | S-lac-NAD | 1.75e-05 | 5 | 277 | 3 | CID000194292 | |
| Drug | sorbarin | 1.75e-05 | 5 | 277 | 3 | CID009824100 | |
| Drug | AC1O5ZB9 | 1.75e-05 | 5 | 277 | 3 | CID006443605 | |
| Drug | AC1L49DG | 1.75e-05 | 5 | 277 | 3 | CID000152931 | |
| Drug | N-trifluoroacetyl-glycine | 1.75e-05 | 5 | 277 | 3 | CID000136227 | |
| Drug | acetylphosphonic acid | 1.75e-05 | 5 | 277 | 3 | CID000081311 | |
| Drug | NSC-60195 | 1.75e-05 | 5 | 277 | 3 | CID000020481 | |
| Drug | ethyl gossypol | 1.75e-05 | 5 | 277 | 3 | CID000374353 | |
| Drug | oxyayanin A | 1.75e-05 | 5 | 277 | 3 | CID005281676 | |
| Drug | B-HAD | 1.75e-05 | 5 | 277 | 3 | CID000131338 | |
| Drug | SQ 31,486 | 1.75e-05 | 5 | 277 | 3 | CID000130015 | |
| Drug | BMS-188107 | 1.75e-05 | 5 | 277 | 3 | CID000192297 | |
| Drug | beryllium nitrate | 1.95e-05 | 14 | 277 | 4 | CID000026126 | |
| Drug | C-PP | 2.01e-05 | 28 | 277 | 5 | CID000001228 | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | DCAF1 RRBP1 SRCAP MTUS2 TRIM46 LAMA4 RGS12 MYOF CAVIN1 ATP1A3 VPS53 | 2.61e-05 | 193 | 277 | 11 | 3166_UP |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | FGF2 STK24 KAT6A CNTNAP1 PRDX2 RGS12 TENM4 ABCB9 LRP4 CAVIN1 ATP2B2 | 2.87e-05 | 195 | 277 | 11 | 2805_UP |
| Drug | BL-443 | 3.47e-05 | 6 | 277 | 3 | CID000054436 | |
| Drug | dansyl-L-lysine | 3.47e-05 | 6 | 277 | 3 | CID000598797 | |
| Drug | I 65 | 3.47e-05 | 6 | 277 | 3 | CID000149068 | |
| Drug | D 701 | 3.47e-05 | 6 | 277 | 3 | CID003051460 | |
| Drug | 2,3-dihydroxy-1-naphthoic acid | 3.47e-05 | 6 | 277 | 3 | CID000028002 | |
| Drug | AC1L24G8 | 3.47e-05 | 6 | 277 | 3 | CID000066023 | |
| Drug | oxymethacil | 3.47e-05 | 6 | 277 | 3 | CID000096369 | |
| Drug | SQ 32,926 | 3.47e-05 | 6 | 277 | 3 | CID000131363 | |
| Drug | 1-methoxy-5-methylphenazine | 3.48e-05 | 16 | 277 | 4 | CID000127832 | |
| Drug | lanthanum | 4.47e-05 | 136 | 277 | 9 | CID000023926 | |
| Drug | E1-P | 4.62e-05 | 33 | 277 | 5 | CID000104406 | |
| Drug | tungstate | 5.34e-05 | 108 | 277 | 8 | CID000001152 | |
| Drug | AC1O7170 | 6.01e-05 | 7 | 277 | 3 | CID006540699 | |
| Drug | BS35 | 6.01e-05 | 7 | 277 | 3 | CID000029316 | |
| Drug | BS36 | 6.01e-05 | 7 | 277 | 3 | CID000029308 | |
| Drug | pentabromoacetone | 6.01e-05 | 7 | 277 | 3 | CID000065579 | |
| Drug | methyl-4-hydroxy-3-nitrobenzimidate | 6.01e-05 | 7 | 277 | 3 | CID005492576 | |
| Drug | gossylic iminolactone | 6.01e-05 | 7 | 277 | 3 | CID005479302 | |
| Drug | N-acetyl-9-O-lactylneuraminic acid | 6.01e-05 | 7 | 277 | 3 | CID000191486 | |
| Drug | sodium glycolate | 6.01e-05 | 7 | 277 | 3 | CID000517347 | |
| Drug | AC1NSM0G | 6.01e-05 | 7 | 277 | 3 | CID005365671 | |
| Drug | diphosphonate | 7.12e-05 | 36 | 277 | 5 | CID006326975 | |
| Drug | bimakalim | 7.20e-05 | 19 | 277 | 4 | CID000060674 | |
| Drug | NSC7524 | ADCY7 ADCY9 ITPR3 PKD1 LDHAL6B PKD1L3 LDHB LDHC ATP1A1 ATP1A3 | 8.24e-05 | 182 | 277 | 10 | CID000005657 |
| Drug | p-(phenoxypropoxy)aniline | 9.54e-05 | 8 | 277 | 3 | CID000423258 | |
| Drug | valrocemide | 9.54e-05 | 8 | 277 | 3 | CID006918293 | |
| Drug | BS37 | 9.54e-05 | 8 | 277 | 3 | CID000027925 | |
| Drug | U75412E | 9.54e-05 | 8 | 277 | 3 | CID003035460 | |
| Drug | AC1Q3O0A | 9.54e-05 | 8 | 277 | 3 | CID000060880 | |
| Drug | UR-12633 | 9.54e-05 | 8 | 277 | 3 | CID000128030 | |
| Drug | 2-methyl-2-pentenoate | 9.54e-05 | 8 | 277 | 3 | CID000018458 | |
| Drug | AC1L4GHU | 9.54e-05 | 8 | 277 | 3 | CID000156607 | |
| Drug | N-dodecyl morpholine | 9.54e-05 | 8 | 277 | 3 | CID000073764 | |
| Drug | S-(2-chloroethyl)-L-cysteine | 9.54e-05 | 8 | 277 | 3 | CID000034229 | |
| Drug | Bay K 8644 | 9.55e-05 | 150 | 277 | 9 | CID000002303 | |
| Drug | vanadyl | SIGLEC5 PTK2 PTPRC KCNQ5 FGF2 VCAM1 PKN3 DYNC1I2 ALPI WRN EGFR ATP2B1 ATP2B2 | 1.08e-04 | 307 | 277 | 13 | CID000061671 |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A | ADCY9 HP1BP3 CNTNAP1 PKD2L1 GRIA4 TRIM3 ATP10D BTBD3 SIDT2 FAM13A | 1.13e-04 | 189 | 277 | 10 | 1742_UP |
| Drug | HMR 1098 | 1.32e-04 | 22 | 277 | 4 | CID003037766 | |
| Drug | bromfenacoum | EDF1 RRBP1 ZFYVE1 HP1BP3 GLB1 MTUS2 HSPA9 CNTN2 TDRKH CNTNAP1 GRIA4 CCDC51 LDHB FXR1 MYH14 NAXD LRP1 ATP1A3 EIF1 ATP2B2 | 1.33e-04 | 644 | 277 | 20 | ctd:C013418 |
| Drug | benzamyl | 1.42e-04 | 9 | 277 | 3 | CID000160884 | |
| Drug | Bcdfg | 1.42e-04 | 9 | 277 | 3 | CID003036106 | |
| Drug | N-acetyl-ala-ala-ala-methyl ester | 1.42e-04 | 9 | 277 | 3 | CID000100120 | |
| Drug | R 8231 | 1.42e-04 | 9 | 277 | 3 | CID003084926 | |
| Drug | bepridil | 1.58e-04 | 126 | 277 | 8 | CID000002351 | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; HL60; HT_HG-U133A | SIGLEC8 SIGLEC5 SRCAP GRHL2 SPTBN5 FGB PEX5 ADAMTS1 TRIM3 ATP1A3 | 1.58e-04 | 197 | 277 | 10 | 2351_UP |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | DCAF1 HP1BP3 TDRKH LAMA4 ANKRD6 MYOF DNAJC17 MYH14 CAVIN1 VPS53 | 1.58e-04 | 197 | 277 | 10 | 6250_UP |
| Drug | alpha-ketovalerate | 1.58e-04 | 23 | 277 | 4 | CID000074563 | |
| Drug | carbimazole | 1.65e-04 | 67 | 277 | 6 | CID000031072 | |
| Drug | fluorobenzene | 1.70e-04 | 43 | 277 | 5 | CID000010008 | |
| Drug | magnesium | EIF4A3 ADGRV1 PSMA8 ADCY7 ADCY9 PTK2 GLB1 JMJD6 ABCC8 FGB PEX5 PKN3 ALPI ADAMTS1 MTHFD1L WRN SLC19A2 LDHAL6B LAMA4 DNM1L GRIA2 GRIA4 BCAR1 LDHB LDHC GFM2 PPM1B EGFR ATP1A1 ATP1A3 ATP2B1 ATP2B2 | 1.74e-04 | 1325 | 277 | 32 | CID000000888 |
| Drug | M-/H | 1.88e-04 | 24 | 277 | 4 | CID000198999 | |
| Drug | geldanamycin | NES SLFN5 PTK2 DMD NIPBL LIMA1 COL12A1 KAT6A LAMA4 EGFR CTNNA1 GALNT5 RASSF8 PCBP2 | 1.97e-04 | 371 | 277 | 14 | ctd:C001277 |
| Drug | caffeine | CYP2J2 ADCY7 ADCY9 ITPR3 PKD1 PYGM DMD ALPI LDHAL6B GRIA2 GRIA4 PKD1L3 LDHB LDHC LTN1 EIF1 ATP2B1 ATP2B2 | 1.97e-04 | 562 | 277 | 18 | CID000002519 |
| Drug | hydroxyisonobilin | 2.01e-04 | 10 | 277 | 3 | CID006438562 | |
| Drug | pyridinophane cryptand | 2.01e-04 | 10 | 277 | 3 | CID006454246 | |
| Drug | sodium oxamate | 2.01e-04 | 10 | 277 | 3 | CID000005242 | |
| Drug | FK3311 | 2.01e-04 | 10 | 277 | 3 | CID000164009 | |
| Drug | 2-keto-4-mercaptobutyric acid | 2.01e-04 | 10 | 277 | 3 | CID000151198 | |
| Drug | bis-NAD | 2.01e-04 | 10 | 277 | 3 | CID003081557 | |
| Drug | mivazerol | 2.01e-04 | 10 | 277 | 3 | CID000060783 | |
| Drug | phosphoenolthiopyruvate | 2.01e-04 | 10 | 277 | 3 | CID000194910 | |
| Disease | fibromuscular dysplasia | 2.99e-06 | 44 | 271 | 6 | EFO_1000938 | |
| Disease | Nonsyndromic Deafness | 9.94e-06 | 81 | 271 | 7 | C3711374 | |
| Disease | Nonsyndromic genetic hearing loss | 7.25e-05 | 76 | 271 | 6 | cv:C5680182 | |
| Disease | Deafness, Autosomal Recessive 12 | 8.40e-05 | 2 | 271 | 2 | C1832394 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 12 | 8.40e-05 | 2 | 271 | 2 | cv:C1832394 | |
| Disease | autosomal recessive nonsyndromic deafness 12 (is_implicated_in) | 8.40e-05 | 2 | 271 | 2 | DOID:0110467 (is_implicated_in) | |
| Disease | Polycystic kidneys, severe infantile with tuberous sclerosis | 8.40e-05 | 2 | 271 | 2 | C1838327 | |
| Disease | Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive | 8.40e-05 | 2 | 271 | 2 | C1837028 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 12 | 8.40e-05 | 2 | 271 | 2 | 601386 | |
| Disease | long QT syndrome (implicated_via_orthology) | 8.77e-05 | 10 | 271 | 3 | DOID:2843 (implicated_via_orthology) | |
| Disease | decadienedioic acid (C10:2-DC) measurement | 8.77e-05 | 10 | 271 | 3 | EFO_0800598 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 1.20e-04 | 11 | 271 | 3 | C4721541 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.38e-04 | 29 | 271 | 4 | cv:C5779548 | |
| Disease | D dimer measurement | 1.58e-04 | 30 | 271 | 4 | EFO_0004507 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.62e-04 | 125 | 271 | 7 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.62e-04 | 125 | 271 | 7 | C1879321 | |
| Disease | Infantile Refsum Disease (disorder) | 2.05e-04 | 13 | 271 | 3 | C0282527 | |
| Disease | hearing impairment | 2.95e-04 | 98 | 271 | 6 | C1384666 | |
| Disease | Peroxisome biogenesis disorders | 3.21e-04 | 15 | 271 | 3 | C1832200 | |
| Disease | Adrenoleukodystrophy, Neonatal | 3.21e-04 | 15 | 271 | 3 | C0282525 | |
| Disease | Zellweger Syndrome | 3.93e-04 | 16 | 271 | 3 | C0043459 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.54e-04 | 148 | 271 | 7 | C0279702 | |
| Disease | apolipoprotein B measurement | ZNF224 RRBP1 PTK2 DDX18 FGB PKN3 LIMA1 ZFP28 PKD2L1 PKD1L3 RGS12 TRIM5 MYOF SIDT2 MACO1 KANK4 | 4.63e-04 | 663 | 271 | 16 | EFO_0004615 |
| Disease | Ciliopathies | 5.48e-04 | 110 | 271 | 6 | C4277690 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 7.71e-04 | 45 | 271 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | blood aluminium measurement | 7.78e-04 | 20 | 271 | 3 | EFO_0007575 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 3B | 8.25e-04 | 5 | 271 | 2 | C3550693 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 2B | 8.25e-04 | 5 | 271 | 2 | C3550234 | |
| Disease | disease of metabolism (implicated_via_orthology) | 9.01e-04 | 21 | 271 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Seizures | 9.67e-04 | 218 | 271 | 8 | C0036572 | |
| Disease | Leukemia, Myelocytic, Acute | 1.14e-03 | 173 | 271 | 7 | C0023467 | |
| Disease | Renal Cell Carcinoma | 1.21e-03 | 128 | 271 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.21e-03 | 128 | 271 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.21e-03 | 128 | 271 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.21e-03 | 128 | 271 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.21e-03 | 128 | 271 | 6 | C1306837 | |
| Disease | Opioid abuse | 1.23e-03 | 6 | 271 | 2 | C0029095 | |
| Disease | Opiate Abuse | 1.23e-03 | 6 | 271 | 2 | C4551628 | |
| Disease | Opioid-Related Disorders | 1.23e-03 | 6 | 271 | 2 | C0027412 | |
| Disease | tetradecadienedioate (C14:2-DC) measurement | 1.23e-03 | 6 | 271 | 2 | EFO_0800585 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.23e-03 | 6 | 271 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Narcotic Dependence | 1.23e-03 | 6 | 271 | 2 | C1527402 | |
| Disease | brain edema (implicated_via_orthology) | 1.23e-03 | 6 | 271 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | Opiate Addiction | 1.23e-03 | 6 | 271 | 2 | C0524662 | |
| Disease | Narcotic Abuse | 1.23e-03 | 6 | 271 | 2 | C0524661 | |
| Disease | Myocardial Ischemia | 1.26e-03 | 176 | 271 | 7 | C0151744 | |
| Disease | descending aortic diameter | 1.33e-03 | 88 | 271 | 5 | EFO_0021788 | |
| Disease | hypertrophic cardiomyopathy | 1.62e-03 | 92 | 271 | 5 | EFO_0000538 | |
| Disease | Neoplasm Invasiveness | 1.62e-03 | 184 | 271 | 7 | C0027626 | |
| Disease | uric acid measurement | INSRR ADGRV1 TENM2 ADCY9 KIAA0319 PYGM TRIM46 STX8 CUBN FAF1 ORC4 MYOF ASXL2 PLAAT5 | 1.66e-03 | 610 | 271 | 14 | EFO_0004761 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.71e-03 | 7 | 271 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Polycystic kidney disease, type 2 | 1.71e-03 | 7 | 271 | 2 | C2751306 | |
| Disease | migraine disorder | 1.83e-03 | 357 | 271 | 10 | MONDO_0005277 | |
| Disease | Bone Diseases, Developmental | 1.90e-03 | 27 | 271 | 3 | C0005941 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 2.12e-03 | 28 | 271 | 3 | DOID:784 (biomarker_via_orthology) | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 2.27e-03 | 8 | 271 | 2 | DOID:0080377 (implicated_via_orthology) | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 2.27e-03 | 8 | 271 | 2 | EFO_0008285 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 2.27e-03 | 8 | 271 | 2 | C0887850 | |
| Disease | Hereditary hearing loss and deafness | 2.36e-03 | 146 | 271 | 6 | cv:C0236038 | |
| Disease | pancreatic cancer (is_marker_for) | 2.44e-03 | 101 | 271 | 5 | DOID:1793 (is_marker_for) | |
| Disease | intellectual disability (is_implicated_in) | 2.59e-03 | 30 | 271 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | myeloid white cell count | CDH23 IFIH1 PTPRC SUPT5H PKD1 MED12L VCAM1 PKN3 FLNB LIMA1 PSTPIP1 UBE2O FAM13A ENAH SSH2 ATP1A1 ATP1A3 IL7R | 2.76e-03 | 937 | 271 | 18 | EFO_0007988 |
| Disease | spontaneous coronary artery dissection | 2.85e-03 | 31 | 271 | 3 | EFO_0010820 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.88e-03 | 152 | 271 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.90e-03 | 9 | 271 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.90e-03 | 9 | 271 | 2 | C0085548 | |
| Disease | cognitive disorder (is_implicated_in) | 2.90e-03 | 9 | 271 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 2.90e-03 | 9 | 271 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 2.90e-03 | 9 | 271 | 2 | C0085413 | |
| Disease | isovalerate measurement | 2.90e-03 | 9 | 271 | 2 | EFO_0021051 | |
| Disease | severe acute respiratory syndrome, COVID-19 | SLFN5 ZFYVE1 TENM2 FBXO10 SEMA5B DMD MXRA5 MTHFD1L WRN C10orf90 ARHGAP6 | 3.02e-03 | 447 | 271 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 3.60e-03 | 10 | 271 | 2 | EFO_0801544 | |
| Disease | Cryptogenic Tonic-Clonic Epilepsy | 3.60e-03 | 10 | 271 | 2 | C0751117 | |
| Disease | Epilepsy, Tonic-Clonic, Symptomatic | 3.60e-03 | 10 | 271 | 2 | C0751119 | |
| Disease | Epilepsy, Tonic-Clonic, Familial | 3.60e-03 | 10 | 271 | 2 | C0751118 | |
| Disease | nephritis (implicated_via_orthology) | 3.60e-03 | 10 | 271 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | Tonic-Clonic Epilepsy | 3.60e-03 | 10 | 271 | 2 | C0014549 | |
| Disease | Parkinsonism (biomarker_via_orthology) | 3.71e-03 | 34 | 271 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 4.38e-03 | 11 | 271 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 4.38e-03 | 11 | 271 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | Substance abuse problem | 4.41e-03 | 116 | 271 | 5 | C0740858 | |
| Disease | lymphocyte count | EPPK1 INSRR CDH23 SIGLEC5 GRHL2 ADCY9 IFIH1 PTPRC DDX18 MED12L FGF2 GIMAP6 SDCBP VCAM1 FLNB LIMA1 PKD2L1 TDRD1 FAF1 UBE2O TENM4 EGFR SSH2 IL7R | 4.57e-03 | 1464 | 271 | 24 | EFO_0004587 |
| Disease | periodontitis | 4.71e-03 | 223 | 271 | 7 | EFO_0000649 | |
| Disease | hair colour measurement | PEX14 ADGRV1 ANKRD27 MED12L ADAMTS1 ZNF618 TRIM41 PARP8 PKD1L3 TENM4 FAM13A LRP1 ASXL2 | 4.80e-03 | 615 | 271 | 13 | EFO_0007822 |
| Disease | cleft lip | 4.95e-03 | 284 | 271 | 8 | EFO_0003959 | |
| Disease | Malignant neoplasm of breast | DDX59 ABCA4 PTPRC SEMA5B JMJD6 DDX18 UTP20 DMD NIPBL FLNB ADAMTS1 LDHAL6B BCAR1 CUBN LDHB FXR1 EGFR CAVIN1 GALNT5 | 5.15e-03 | 1074 | 271 | 19 | C0006142 |
| Disease | nervous system disease (implicated_via_orthology) | 5.22e-03 | 12 | 271 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 5.22e-03 | 12 | 271 | 2 | EFO_1001304 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 5.22e-03 | 12 | 271 | 2 | EFO_0008284 | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.22e-03 | 12 | 271 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 5.22e-03 | 12 | 271 | 2 | DOID:9477 (biomarker_via_orthology) | |
| Disease | Cleft upper lip | 5.49e-03 | 39 | 271 | 3 | C0008924 | |
| Disease | calcium measurement | ITIH1 SEMA5B PKN3 TRIM46 NUMA1 SIGLEC14 RGS12 KAT7 EBLN1 RCL1 ATP1A1 ATP1A3 ATP2B1 | 5.69e-03 | 628 | 271 | 13 | EFO_0004838 |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 6.13e-03 | 13 | 271 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Zellweger Spectrum | 6.13e-03 | 13 | 271 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 6.13e-03 | 13 | 271 | 2 | C0751594 | |
| Disease | Mesothelioma | 6.31e-03 | 41 | 271 | 3 | C0025500 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 6.75e-03 | 42 | 271 | 3 | DOID:612 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 7.11e-03 | 14 | 271 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 7.11e-03 | 14 | 271 | 2 | DOID:627 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLQARVVEVTENGIG | 856 | Q9BXT4 | |
| VETGGQDSVRQARKE | 426 | O95429 | |
| IENAKQVGRLENAIG | 121 | Q92905 | |
| GQGIEVQVRGLETEK | 1191 | P53355 | |
| QQTVGSRLQALRGEE | 236 | O43822 | |
| KVDGQLVNLTLVEGR | 511 | P78357 | |
| VKTVRGSLERQAGQI | 121 | Q6NZI2 | |
| IQVQAGKGINISART | 1271 | Q7Z407 | |
| VQVIGALIGKQEGRN | 66 | Q7L5N1 | |
| IENETERISGNNKGV | 111 | O00429 | |
| KVQAEIDRVIGQGQQ | 336 | P51589 | |
| VAEERQRIITGGNKT | 1921 | P78363 | |
| QASRIAKEEVNGQVL | 216 | P30939 | |
| GSITRQGKSQLELQQ | 686 | P56945 | |
| QGTKEGREAVSQLQT | 236 | Q8NEB7 | |
| ASGVEARQALLKQGQ | 171 | P30040 | |
| NGKGLITENVIRENQ | 586 | Q9UK96 | |
| IRVSGVGNNISFEEK | 96 | A8K2U0 | |
| EKGETLIFEVGSRQQ | 1056 | Q8WXG9 | |
| NVQADGKIQVDGRTR | 811 | Q96L96 | |
| AVQTKRVAAQVDGGA | 806 | O95782 | |
| QLGEQTKLSREQIEG | 231 | Q9BR77 | |
| KLQALTGNEGRVSVE | 31 | Q6FI81 | |
| TGNEGRVSVENIKQL | 36 | Q6FI81 | |
| KGESVLQRVQSVAGN | 401 | Q96P50 | |
| IELKRQGVVLGQNLS | 426 | Q9Y2F9 | |
| QGALQLKQDFGVVRE | 601 | Q17RM4 | |
| NIATEIKDGQIRGTV | 1211 | A6QL64 | |
| QQRNGRKTLTTVQGI | 36 | O60739 | |
| EGTVKELLQRGDNLQ | 1821 | P11532 | |
| KELQDGIGQRQTVVR | 2146 | P11532 | |
| QAIKQVREATGVDIN | 356 | P51828 | |
| REDTGDQQGLLKAIQ | 151 | Q13111 | |
| DRFLRKITIGQGNTE | 581 | Q6UB35 | |
| EINGVTQGDRSRALK | 391 | A4D256 | |
| QGVITRKVNIQVGDV | 111 | Q9H251 | |
| GIQGVVRKTVNDELR | 171 | Q14156 | |
| HKVGQGENQRITREE | 206 | Q6NXP0 | |
| SRIEQEQKFTVIRGG | 186 | P20020 | |
| EQKFTVIRGGQVIQI | 191 | P20020 | |
| GLQSRIEQEQKFTVV | 181 | Q01814 | |
| IIENEDLQGNAKRVG | 326 | Q8TBG4 | |
| EVAAGQVLKGTFRQN | 746 | O14525 | |
| QVIQREGLKEIRSGT | 36 | Q76L83 | |
| GLDGESNLKQRQVVR | 211 | Q9P241 | |
| GQTENVVQLINKGAR | 21 | Q9Y2G4 | |
| SNGSLLKVDVQGEIR | 201 | O00189 | |
| QRAVERGQLEQITGK | 306 | Q5SSJ5 | |
| TNEVAQLIQGGRLIK | 86 | Q9Y5U8 | |
| EQQTRQLGVAQGELK | 1006 | Q5JR59 | |
| DKITNGSRIEINQTG | 56 | Q9Y2P8 | |
| GQQSLRLENGIKAVE | 306 | Q8NHQ8 | |
| VQKTLLADQGEIRVG | 136 | O94776 | |
| ENDTGLQAQDIRGRK | 941 | O14715 | |
| TGATNIEVKQRNQRG | 746 | Q9UHI8 | |
| QQAKIESDRVIGSVG | 461 | Q9UL03 | |
| RSNGDNVVVGDKVIL | 171 | Q14573 | |
| GRQVGQVAKQQVASL | 536 | Q96RS6 | |
| IIVESGKRVGVAVQQ | 1661 | O94822 | |
| NIATEIKDGQIRGTV | 1041 | Q5JPF3 | |
| QTLNGKDVFIQGNRI | 66 | Q96NW4 | |
| QQELGRQADELKGVR | 126 | Q8IYY4 | |
| RQLNLENVVGDKVFG | 116 | O43929 | |
| QQLLKGQETRFAEGI | 41 | Q53RD9 | |
| ELNTIVQQFKRVGAE | 61 | Q9UM21 | |
| ELVQIARKAGGQTEI | 56 | O43586 | |
| LEQVKQSLQRTEGGI | 536 | Q9Y4B6 | |
| NINTQEGGIHKEILR | 831 | Q8N3A8 | |
| KEIRESTGAQVQVAG | 121 | Q15365 | |
| LEKLRLQGQITEGSN | 321 | O95251 | |
| ELIKVTRDEGGNQQD | 216 | Q6NYC1 | |
| KGQDEQREGLLTSLQ | 1476 | Q86YW9 | |
| QSEESVGGRVAERKQ | 621 | Q9UHB6 | |
| IIGGRDQQQNEIIVK | 541 | O60524 | |
| GEIRNLENVIQSQRG | 206 | Q68CZ1 | |
| GISNIKAIGVSNQRE | 81 | Q14409 | |
| GSEIVVAGRIADNKQ | 506 | P19827 | |
| SGVVRVRIEGDNENK | 311 | P51114 | |
| GLERQVAGLQQEKES | 946 | Q9BQS8 | |
| TQAIKRAFINGTGVE | 1636 | Q07954 | |
| QQKLIIVEGCQRQGA | 696 | P05023 | |
| AQVVKGLQGTNRQLE | 151 | Q8N4P3 | |
| SLQTRVDQILGKGQI | 566 | Q9NR82 | |
| QIIKGRDVIAQSQSG | 71 | P38919 | |
| IKSLQTRVDQIVGRG | 576 | P56696 | |
| QEQFKVDREGGLNTV | 276 | Q9UBV7 | |
| ERNNVITLNITGKAG | 456 | P16278 | |
| DVERFKQQGGNIIVA | 126 | Q8NHQ9 | |
| EGEIQAGAKLSLNRQ | 256 | Q13409 | |
| KQQLGILVQGQEVTR | 186 | Q5T1V6 | |
| GGSQSETEVRQKQQL | 111 | Q96J88 | |
| QQVKALGTERTTLEG | 176 | Q9BW19 | |
| EVLGTLQRGKEENIS | 556 | Q13144 | |
| QQRNGRKTLTTVQGI | 36 | P41567 | |
| LGDAKRQLEIAQGQI | 586 | Q8N5G2 | |
| DRVTLEVGKVIQQGR | 71 | O60869 | |
| RALKQVQVEGLSGNI | 346 | P42262 | |
| ERTLKQVRIQGLTGN | 346 | P48058 | |
| KIFAQDGEGQRIDIQ | 681 | O75369 | |
| VIQNRQDGSVDFGRK | 281 | P02675 | |
| QQSAREVGELQGRVA | 886 | Q7Z406 | |
| GARQEKGETRLNLVQ | 146 | Q9BYZ2 | |
| LKFVRQIGEGQVSLE | 216 | P50542 | |
| VQGLSAEEIRNGNLK | 156 | Q8IVL0 | |
| LQGVVRKTVNDELQA | 171 | Q9Y2G0 | |
| VARQLIDEKVGGTNL | 416 | Q96I24 | |
| RILKQVSGGEDEIQQ | 1636 | Q6KC79 | |
| QALGNVTVVQKGERD | 236 | Q8IW45 | |
| VTVVQKGERDILSNG | 241 | Q8IW45 | |
| KGERDILSNGQQVLV | 246 | Q8IW45 | |
| ETQSQKVGQLAARGI | 661 | Q9Y239 | |
| KQGLQSQIAQVLEGR | 271 | P48681 | |
| GRNGVSDVVKINLNS | 296 | P07864 | |
| REVQGTSENGVIFQK | 156 | Q86UK5 | |
| RDGKLLLSQNVEGIQ | 391 | Q8TB73 | |
| RNKGQGTRAVQEKET | 581 | Q96MY7 | |
| NLKREVENGNGISVE | 196 | Q68G74 | |
| GKVEIIANDQGNRTT | 26 | P34931 | |
| QRQATKDAGVIAGLN | 156 | P34931 | |
| KIQQDADSVITVGRG | 386 | Q9H3P7 | |
| QLEESEKQRLGGDVQ | 331 | P16871 | |
| AEQVGKEGRSGQRNV | 216 | Q8N8V4 | |
| SQRQKIAEEIGIEGS | 281 | Q9Y5B6 | |
| RSAEAQKLGNGINII | 291 | Q9NVP1 | |
| QEGLFRVNGNVKVVE | 76 | O94988 | |
| GDIVVGRITEVQQKR | 81 | Q13868 | |
| DKGTGREQQIVIQSS | 536 | P38646 | |
| REQQIVIQSSGGLSK | 541 | P38646 | |
| IIDGKGVLRQITVND | 131 | P32119 | |
| LEIKGTNGQVTRADI | 281 | Q9H074 | |
| VERRGSGKVINQVSL | 581 | Q86Y26 | |
| KEIRESTGAQVQVAG | 121 | Q15366 | |
| SQNGIRLDGKNLVQE | 241 | P09923 | |
| GGQAAEREQQVTQKK | 911 | O43182 | |
| IGGVLRAEQQIKDNL | 31 | Q13772 | |
| RDIQEQALQKVGVTG | 486 | Q92794 | |
| VNGEAGELELQRQKR | 21 | O60494 | |
| AQGLKQVLQTLEQRG | 541 | Q9UFP1 | |
| VGVSKRSNIVIGNEN | 96 | P0CF75 | |
| RSNIVIGNENKETGT | 101 | P0CF75 | |
| QVLSEVGFQKGTRQL | 156 | P0DPD8 | |
| ENLEIIRGRTKQHGQ | 421 | P00533 | |
| QRVRGLEEQVSTLKG | 1981 | Q5TZA2 | |
| GTLSIQRVEIQDRGQ | 1706 | Q6WRI0 | |
| IVREAAVQGDGQKQR | 971 | Q9Y2F5 | |
| NLSGGENRVQVLKTV | 106 | Q6ISB3 | |
| RNKGQVQVADLLGIN | 1156 | Q6ZP82 | |
| ETEQLNKLSRGDGRQ | 321 | Q5JSL3 | |
| VKAEVQNLGGELVVS | 796 | P35221 | |
| DISNIKAVGVSNQRE | 81 | Q14410 | |
| RQQEISGFVAQIEKL | 501 | P0C221 | |
| VRGDTTNTVLQGLKE | 861 | Q99715 | |
| GKRNIEEILTARGEQ | 121 | Q5SXM8 | |
| VLQDINRKGGTNGVQ | 931 | Q8TD26 | |
| GREKAQLQEQVGQVT | 711 | H7BZ55 | |
| GLDVGNLTQQRELRK | 771 | Q7Z7M9 | |
| QQVKTNGAGVTVLRR | 266 | Q9NVF7 | |
| IRVKLGQGNSQERVE | 701 | Q86WZ0 | |
| KDQEVLLQTGRALGN | 101 | P52306 | |
| ENNGNESGVRELLKR | 156 | Q9BYX4 | |
| VDAVRKSLQGVAGVQ | 26 | O14618 | |
| IERLGQSVVADQLKG | 551 | O60503 | |
| TEAVAEKLGQQVNRT | 156 | Q8J025 | |
| SELNAGKGRERQILQ | 831 | Q68DC2 | |
| GKGRERQILQETIHN | 836 | Q68DC2 | |
| SKGRDTVQGRIIVQA | 311 | Q02246 | |
| EERENIDIQGKTVIG | 391 | Q8NFW1 | |
| QRLRGKAENTEGQGT | 156 | Q9NVM6 | |
| RLSEEVEQKIAGQVG | 221 | Q8TF61 | |
| VEQKIAGQVGRLQAE | 226 | Q8TF61 | |
| LEEVTGTRGRQNKAE | 456 | P14616 | |
| QQKLIIVEGCQRQGA | 686 | P13637 | |
| QLQAEERGVVSIKGV | 196 | P09038 | |
| KLLREGNVNIQATQG | 881 | Q5T7N3 | |
| KIVVVTAGVRQQEGE | 91 | P07195 | |
| TAGVRQQEGESRLNL | 96 | P07195 | |
| TGNNTFRVVGRKIQD | 41 | Q8N8S7 | |
| GKRSSNEVLNVIQGN | 456 | Q9UNN5 | |
| QRQISLEGSVKGIQN | 81 | O95810 | |
| QIQRVILGAKEGTQE | 1171 | Q9C0D2 | |
| QTGNIREEVTNKLIG | 306 | Q7Z3Z3 | |
| VKDLGQGIQNSVTDR | 521 | Q92681 | |
| VTGNDVGIRRAEIKQ | 96 | O00560 | |
| RVNGIKVQNGGIVTD | 226 | O60779 | |
| QLENASRVNIQGGKE | 616 | Q9H329 | |
| ENVAEINRQVGQKLG | 71 | O43933 | |
| GIKEANQTQLREIAG | 571 | A6NMZ7 | |
| VKRGEGRAVNITSEN | 406 | P02748 | |
| QTVAVVNRRGQVTGK | 1121 | Q5VU65 | |
| QKVQGDSLVILSGRD | 2011 | P98161 | |
| DRIHGTEEGQQILKQ | 41 | Q14980 | |
| LAVLKVDNRVVGQTG | 331 | Q6P5Z2 | |
| KNGQVIVKVNNGIRD | 1701 | Q16363 | |
| NGLVENFTIERRVKG | 2651 | O75445 | |
| EIERTIKNIQGTITG | 1771 | O75691 | |
| QNTFGQLQLRVVKEG | 231 | Q8WVZ7 | |
| SQQGGLRLLQDIKET | 371 | Q8WV44 | |
| GQQAKEEVSQLVRGL | 306 | Q7Z4K8 | |
| GINQAGRSRKEVELI | 581 | P19320 | |
| QEIQTRQDNKVVIGF | 716 | Q969S9 | |
| FAGTGEQKEEQRQVL | 116 | Q17R31 | |
| RTEGVRVSVNVLNKQ | 61 | Q8NBJ9 | |
| VIGSNTVVEAKGQRV | 246 | Q99719 | |
| LDEERGAQVQVLQGK | 1836 | O95425 | |
| KTRLQLQGELQARGT | 31 | Q6PIV7 | |
| KELQERQVSQGQGSE | 246 | Q6P9H5 | |
| KVRTQIITNTAERGN | 1296 | O14513 | |
| GLNEVREAQGKVTEA | 91 | Q96ER9 | |
| GVAGQLTDTQIKRNT | 176 | Q9Y6E0 | |
| GEVFKGIDNRTQQVV | 36 | Q9P289 | |
| GRKLRSEQGVQVILD | 341 | Q1AE95 | |
| VKNNDVIGRIENGER | 626 | Q05397 | |
| QNQGIKVAAIRGEVT | 1841 | P58107 | |
| KDLDNRNIVGSIGSV | 476 | Q7Z443 | |
| QQTNVALLGRETVGK | 301 | Q7Z5V6 | |
| GRKSLGQELRVNNVT | 96 | Q6P435 | |
| KRQGAQVTTERTVQL | 216 | O15389 | |
| REVQAETQGRFQLLG | 86 | Q9NYZ4 | |
| LGELQHQQDRGSVVK | 76 | Q86WV5 | |
| TEGEKQQLLSTGRVQ | 2726 | Q9NT68 | |
| EDSTTGGVQQKQIRE | 321 | Q14191 | |
| GGVQQKQIREHEVLI | 326 | Q14191 | |
| ELSVENVKNGIRTGF | 96 | O75688 | |
| RDNELIGQTVRISQG | 701 | O00267 | |
| QRGGSLQEENKVTQK | 2281 | Q9P2P6 | |
| EQAQQGKREKLGVQV | 3431 | Q9P2P6 | |
| IQGNKLTLTGAQVRQ | 1211 | Q6ZRS2 | |
| AVRDVGGQLQRLTQV | 1496 | A1L4H1 | |
| LRETVVQQKETLGAQ | 66 | P47972 | |
| RGGDGQINEQVEKLR | 351 | O75381 | |
| QRRIKLGVTQADVGA | 196 | Q15319 | |
| NTLRVLGQQGQELKV | 1181 | Q9NRC6 | |
| GQEDIQTRLQGLRSK | 1386 | Q9NRC6 | |
| VVLDKGRVVQQGTHQ | 711 | Q9NP78 | |
| EIVTNIQRGFIESGK | 51 | Q8NF67 | |
| DAQVRKDIQGTQGAR | 271 | Q09428 | |
| SVDGRQIRVDQAGKS | 71 | Q14011 | |
| TELANVGANQVTVRK | 371 | Q96M02 | |
| GIARAVVEGQLQVAK | 186 | Q9H3H3 | |
| TVKQEEIQGGDVRTA | 976 | A4UGR9 | |
| LLQGVDGVIKRTENV | 246 | Q9C035 | |
| GRKLAVGQETQFRQE | 346 | Q8NHY6 | |
| NQVRKELQAEATVSG | 81 | Q9BZV1 | |
| EGDQILKVNTQDFRG | 551 | Q9UDY2 | |
| GVQQGIEQRVKSFNV | 201 | P61129 | |
| VVIGGVRNQQTLDGK | 101 | Q5T7W0 | |
| QEEKSNRVLVVDLGG | 431 | O14924 | |
| LQGKIRTLQEQLENG | 776 | Q9P2E9 | |
| GRKLRSEQGVQVILD | 341 | Q8IXX5 | |
| QEAVKLIIGRQGANI | 61 | Q9Y2W6 | |
| LKRGDQIIAVNGQSL | 2031 | O75970 | |
| NGEVITNKGRKQIRE | 121 | Q5VZ03 | |
| RKQISVRGLAGVENV | 11 | P11217 | |
| TGTQQEGVLKDLRTV | 976 | Q76I76 | |
| VGAGTKLNSVRQQQL | 61 | Q5TF21 | |
| DGVSRQQNAVGREKE | 301 | A1X283 | |
| TNKVDRSVGGLVAQQ | 681 | O15067 | |
| LQGGVQEVQDTVLKQ | 371 | Q96GC6 | |
| RIQVAQEKQVAEQGG | 421 | O94804 | |
| LERDKVVGQISGLQE | 246 | Q8N0X2 | |
| VQVDGQARTQKLQGL | 3801 | P22105 | |
| SVITQENLGRVKRLG | 326 | Q9C0C9 | |
| TEGEKQQVLSTGRVQ | 2721 | Q6N022 | |
| AVEKRGQQGTITLDD | 106 | Q96LQ0 | |
| RQVGNLSRTIEKING | 211 | Q9P283 | |
| ETRGLGFDEIRQQQQ | 131 | Q9UNK0 | |
| RIRDNVKNTGETGVE | 1411 | O00507 | |
| SERVKAAQTELGQQI | 201 | Q5VIR6 | |
| RVSDVQKVLQGGEQE | 601 | Q9P0L9 | |
| QFTRVGVQVLDRKDG | 81 | Q6UW63 | |
| INVSRQQVEKVFGLE | 106 | Q6ZN44 | |
| LIARKVGEAVQNTLG | 676 | Q9HBF4 | |
| RVKGLESSQQIISGE | 81 | Q2M218 | |
| NQLGREVDTSLNGRV | 86 | O15090 | |
| NGNRIVDVNLTSEGK | 166 | Q9HD45 | |
| GVRQKIFQVAQELSG | 96 | Q99598 | |
| RGSEQGKRVENINGT | 111 | Q8NB50 | |
| VQKEGQGSQTLRVEK | 71 | Q6PML9 | |
| QVAFLQGERKGQENL | 96 | Q9NRL3 | |
| LEQGRSIQQGEKAVV | 81 | Q96KN8 | |
| IRQGIQLKSVADGQE | 441 | O00401 | |
| AIQREGNSGDKIQTE | 71 | Q9NZL3 | |
| VVQSGGKNIELAIIR | 206 | Q8TAA3 | |
| NKIVNVSLADLRGGN | 376 | Q9HAU0 | |
| EGTRAFGDVVVKINQ | 771 | P08575 | |
| RGGQTVKSLRIQEQV | 46 | Q99959 | |
| QVEQSRSQVQAIGEK | 36 | Q9NQA3 | |
| VDAGKVTLGTQQRQE | 16 | Q08AF3 | |
| KRQGAQVTTERTVQL | 216 | Q08ET2 | |
| KLESQAGQQVSRGAR | 1111 | P49815 | |
| ALVGGISQQLQERKA | 181 | O75382 | |
| GAVNNTGKVLELVRN | 466 | Q5TIE3 | |
| TLQVGVGQLTEQRKD | 821 | Q5VV43 | |
| GNSIQRLGEVNKLAV | 111 | Q96E66 | |
| SGRNKETVLANVEGL | 1586 | O75096 | |
| GTLVIRKVQVQDRGQ | 1911 | Q9NR99 | |
| EKFRVQGEAVGNIQE | 141 | Q9H009 | |
| RLQTNIEALKSGIQG | 666 | Q9NZM1 |